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NKp46+ CD3+ T cells have been defined as a novel non-conventional T lymphocyte subset 
of cattle that express both NK cell and T cell receptors. It has been hypothesized that 
NKp46+ CD3+ cells may form a niche bridging the innate and adaptive immune response 
and there is now evidence they may play a role in the responses against Theileria parva and 
Mycobacteria. Thus, NKp46+ CD3+ cells may offer a novel population to target in 
vaccination strategies. In bovine, recent studies have shown that NKp46+ CD3+ cells can 
recognize and respond to autologous Theileria parva infected cells (TpM) and that NKp46+ 
CD3+ cell lines can be generated and maintained in vitro. Functional analysis has indicated 
that both NKp46 receptor and CD3 (i.e. TCR) cross-linking can lead to cell activation, 
however, the function of the T cell receptor is still not clear. The aim of this study is to 
analyze the TCR repertoire of TpM-stimulated NKp46+CD3+ populations to look for 
evidence of TCR selection that would indicate a role for TCR in mediating recognition of 
TpM. To address this aim, we use high resolution NGS TRB sequence analysis to compare 
the TCR repertoires observed in TpM-stimulated and non-specific stimulated NKp46+CD3+ 
populations derived from naïve and T. parva-immune animals. TpM specific-stimulated 
NKp46+CD3+ cell lines were successfully generated from naive and T. parva immunized 
cattle, but generation and maintenance of NKp46+CD3+ cell lines through use of non-
specific stimulant was unsuccessful. The results of this study provide evidence of clonal 
selection in the T. parva-specific response of NKp46+ CD3+ T-cells and in 2 naïve animals 
highly overlapping TRB repertoires. From the current data it is confirmed that NKp46+CD3+ 
cells express a highly diverse TRB repertoire with no obvious and consistent overt bias for 








Conventionally, the immune system can be divided into innate and adaptive components. T 
lymphocytes play an important role in adaptive immunity, whilst natural killer (NK) cells are 
classified as a part of the innate immunity. T cells are defined by expression of the T cell 
receptor (TCR) and the associated CD3 molecule. NKp46 is a natural killer receptor 
expressed by NK cells and was considered to be a marker specific for this population. A 
novel lymphocyte subset—NKp46+ CD3+ cells - has been recently described in cattle and 
over livestock species, which co-expresses NKp46 and CD3 and exhibits features of both NK 
cells and T cells. Previous studies have demonstrated that NKp46+ CD3+ cells play a role in 
the responses against Theileria parva and tuberculosis, therefore this cell subset may be a 
target for novel vaccines. Moreover, these studies proved that NKp46+ CD3+ cells could be 
stimulated by both NKp46 receptor and CD3 signalling pathways (i.e. TCR). However, the 
role of the TCR in mediating recognition of target cells by NKp46+CD3+ cells is still not 
clear. The aim of this project is to investigate the TRB repertoire of NKp46+ CD3+ cells that 
have been stimulated with autologous T. parva-infected cells to look for evidence of clonal 
selection and/or biased TCR usage that could indicate a role for TCR mediated selection and 
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Chapter 1. Introduction 
 
1.1 T cells 
The immune system provides organisms with defence against invasion by a wide variety of 
pathogens. Conventionally, the immune system can be classified into innate and adaptive 
components. Adaptive immunity is mediated by two lymphocyte subsets—T-cells and B—
cells. B-cells produce immunoglobulin (Ig) that provides humoral immunity, whereas T-cells 
are involved with provision of cell-mediated immunity. In contrast to innate immunity, the 
adaptive immune system is characterised by 1) the requirement for initial priming, 2) 
recognition of antigen via a somatically rearranged heterodimeric antigen-specific receptor 
(TCR or Ig) and 3) formation following primary antigen exposure of long-term protective 
immunological memory. However, recent studies have shown that components of the innate 
system also appear to have the capacity to form ‘memory’ (Netea 2013).  
 
T cells can be divided into two lineages based on expression of either an αβ or γδ T cell 
receptor (TCR). Generally, αβ T-cells can further be subdivided into two populations co-
expressing either the CD4 or CD8 co-receptor. CD8+ T cells are also known as CTL 
(cytotoxic T-cell lymphocytes) and can have the capacity to lyse target cells as well as 
produce cytokines such as interferon-γ (IFNG) and tumour necrosis factor-α (TNFA). CD4+ 
T cells are also referred to as Helper T cells (Th cells) and frequently are involved in 
facilitating the functions of other immune cells – for example antibody production by B-cells, 
activation and proliferation of CTL-cells and assisting phagocytes to destroy ingested 
microbes by releasing T-cell cytokines. There are at least four different Th cell subsets that 
are defined by the expression of different ‘master regulator’ transcription factors: Th1 (T-
bet/STAT4), Th2 (GATA-3/STAT5), Th17 (Rorγt/STAT3) and induced T-regulatory cells 
(Foxp3/STAT5), each of which has distinct effector functions in regulating the immune 
response. Th1 cells are essential for macrophage activation, cell-mediated immunity and 
phagocyte-dependent protective responses by secreting cytokines (Saraiva et al. 2009); Th2 
cells have a role in eosinophil activation and inhibition of several macrophage functions (Paul 
& Seder 1994); TH17 cells participate in neutrophil activation through production of IL-17a, 
IL-17f and IL-22 (Harrington et al. 2005) and iTreg cells (also known as suppressor T cells)  
function in down-regulating induction and proliferation of effector T cells (Takahashi et al. 
1998). 
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1.2 The αβ T cell receptor 
The αβ T cell receptor (TCR) is a heterodimeric, somatically rearranged, clonotypicallly 
distributed receptor, which in conventional T-cells is responsible for recognizing peptide 
fragments presented within the context of host MHC molecules and thus dictates epitope-
specificity. Each protein chain of the TCR is composed of two extracellular domains: 
Variable (V) region and Constant (C) region, and is expressed on the cell surface of the T-cell 
in conjunction with the cluster of differentiation 3 (CD3) complex (Figure 1.1). The structure 
of TCR is crucial for understanding the function and formation of TCR.  
 
	
Figure 1.1 Structure of the T cell receptor. The T cell receptor heterodimer is composed of two glycoprotein 
chains, α and β chain (blue). Each chain consists of two domains, variable (V) region and constant (C) region. 
The CD3 molecules (CD3γ , CD3δ, and CD3ε) in yellow and orange, and ζ-chain accessory molecules in green 








1.2.1 Somatic recombination of αβ TCR 
To enable recognition of the vast array of different peptide antigens, conventional T-cells 
express a hugely diverse αβ TCR repertoire that is generated by V(D)J recombination during 
the early stage of T lymphocyte maturation in the thymus. This recombination involves the 
assembly of individual V (variable), D (diversity-β chain only), J (joining),  and C (constant) 
gene segments in α and β chains (Tonegawa 1983) (Figure 1.2). Recombination signal 
sequences (RSS) flanking the 3’ end of V, the 5’ end of J, and both 5’ and 3’ ends of the D 
gene segments, are recognised by a hetero-multimer encoded by recombination activating 
genes 1 and 2 (RAG1, RAG2) which initiates somatic rearrangement. The RSS is composed 
of heptamer and nonamer motifs separated by a spacer of either 12bp (12-RSS) or 23bp (23-
RSS) length, the V genes are flanked by 23-RSS, the J genes by a 12-RSS and the D genes 
are flanked by a 5’end 12-RSS and 3’ 23-RSS (Hesse et al., 1989). The requirement for 
recombination to occur between 12-RSS and 23-RSS genes (the 12/23 rule) ensures ordered 
rearrangement, with the molecular mechanisms upon which this dependent having recently 
been established (Ru et al. 2015). More than75% of αβ TCR diversity is produced by this so 
called ‘combinatorial diversity’ (i.e. different V(D)J permutations), which is then further 
amplified by the activity of exonuclease and terminal deoxynucleotide transferase (TdT) 
which  respectively remove and insert bases to the 5’ end of V, the 5’ and 3’ end of D and the 
3’ end of J gene segments – termed ‘junctional diversity’ (Gauss and Lieber 1996).  
 
Figure 1.2 Schematic illustration of somatic recombination of TCRα and TCRβ genes. The αβ TCR consist of 
three different gene segments: variable (V)—red, diversity (D)—green, and joining (J)—blue gene segments. αβ 
TCR are generated by somatic recombination of V and J gene segments for the TCRα chain and V, D and J gene 
segments for the TCRβ chain. Rearranged gene segments are then splicned with constant (C) region (yellow) to 
form the functional αβTCR. During somatic recombination, non-germline (N) regions (black) are generated due 
to nucleotide additions and deletions (Turner et al. 2006).  
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In each of the rearranged αβ TCR genes there are 6 loops called the Complementarity 
Determining Regions (CDRs). These form the membrane-distal surface of the TCR and 
directly interact with the peptide-MHC ligand.  Three CDRs are derived from the α chain 
(CDRα1, CDRα2 and CDRα3) and 3 from the β chain (CDRβ1, CDRβ2 and CDRβ3) 
(Garboczi et al. 1996; Garcia et al. 1996). The CDR3s are encoded by the V(D)J junction, 
which as this is non-germline encoded is hypervariable and consequently the  most 
polymorphic of the CDRs. The CDR1 and 2s are encoded within the V gene germline 
sequence and so their diversity is determined by the genome repertoire.  
 
1.2.2 TCR loci in human and mouse  
The gene segments encoding the TCR are located in 3 genomic loci – TRA/D (which 
includes the TCRα and TCRδ gene segments), TRB (TCRβ) and TRG (TCRγ). Sequencing 
of these loci has permitted comparative descriptions of the genomic repertoires in a number 
of species (Rowen et al. 1996) and subsequent comparative analyses. The TRA/D loci in 
humans and mice are located on chromosome 14q11.2 and 14c2 respectively. The human 
TRA/D locus contains 54 TRAV genes belonging to 41 Vα subgroups (V gene subgroups are 
defined by members sharing >75% nucleotide sequence identity), 3 TRDV, 3 TRDJ, 3 
TRDD, 61 TRAJ, and single TRAC and TRDC genes. The mouse TRA/D locus has 100 
TRAV genes which are distributed across 23 Vα subgroups, 6 TRDV, 2 TRDJ, 2 TRDD, 61 
TRAJ, and single TRAC and TRDC genes (Table 1.1). The TRG loci are located on 
chromosome 7p14 in human and chromosome 13 in mice, and consist of 14 TRGV and 5 
TRGJ genes, and 7 TRGV and 4 TRGJ genes respectively. The TRB locus includes 64-67 V 
(classified into 32 subgroups), 2 D and 14 J gene segments in human, and 35 V (classified 
into 31 subgroups), 2 D and 14 J gene segments in mouse (Table 1.1) and are located on 
chromosome 7q34 and chromosome 6A-C, respectively (Barker et al. 1984; Caccia et al. 
1984). The structure of the TRB loci in human and mouse are very similar (Figure 1.3), with 
the majority of the V genes located at the 5’ end and 2 tandemly arranged DJC clusters 
(comprising a single TRBD gene, 6-7 TRBJ genes and a single TRBC gene) with a single 
TRBV gene with an inverted transcriptional orientation located at the 3’end of the loci 













Figure 1.3 Schematic representation of the human and mouse TRB loci (IMGT database). TRBV genes are 
classified as functional , ORF , pseudogene , and other TCRβgenes: Dβ genes—purple vertical line, Jβ 
gene cluster  , Cβ gene  , non-TCRβgene: Trypsinogen . The human (upper) and mouse loci are shown 
from the 5’ end to 3’ end. 
 
1.2.3 TCR loci in cattle  
Compared to humans and mice, the cattle TRA/D and TRB loci are characterised by a 
massive expansion of Vα and Vβ genes (Connelley et al. 2009; Connelley et al. 2014) the 
cattle TRA/D locus is located on chromosome 10 and contains 371 TRAV/TRDV genes 
(distributed into 42 subgroups), 62 TRAJ, 3 TRDJ, 6 TRDD, and single TRAC and TRDC 
genes, whilst the TRB locus is located on chromosome 4 and includes 134 V genes belonging 
to 24 subgroups (Table 1.1). Notably in both loci this expansion has predominantly occurred 
through the duplication of ‘gene cassettes’ which contain multiple V genes and have led to 
the massive expansion of some of the V gene subgroups; in the TRB locus around 68% of 
genes belong to TRBV6, 9 or 21 subgroups. This massive duplication, with over-
representation of certain V gene subgroups has obvious implications of the diversity and bias 
in the expressed TCR repertoire. The schematic representation of the cattle TRB loci shown 
in Figure 1.4  represents the duplication events observed which, in addition to the expansion 



















Figure 1.4 Genomic organisation of genes in the bovine TRB locus (Connelley et al. 2009). Undetermined 
sequence in red dotted lines; TRBV functional genes—green; TRBV non-functional genes—orange; 
pseudogenes genes— red; TRBD genes—blue vertical lines; TRBJ genes—pink vertical lines. TRBC genes—
yellow boxes; bovine TRB enhancer (Eβ)—black diagonal shading; non TRB genes—black box. Regions of 
duplicated DNA are indicated by the colour-coordinated boxes located beneath the scheme of gene location. 
Broken lines indicate regions of DNA that are not present in all copies of the duplicated region. 
	
Table 1.1 Summary of the number of αβ TCR gene segments in human, mice and bovine. Number in 
parenthesis shows the number of subgroups. Human and murine repertoire data obtained from the website 
http://www.imgt.org/IMGTrepertoire/. Bovine genome repertoire data obtained from [Connelley et al. 2009; 
Connelley et al. 2014].   
 
  αβ TCR diversity 
TCRA   TCRB 
V J C V D J C 
Humans 
Total 54 (41) 61 1 64-67 (32) 2 14 2 
Functional 45(34) 50 1 36 (23) 2 10 2 
Mice 
Total 100 (23) 61 1 35 (31) 2 14 3 
Functional 71 (19) 49 1 21 (19) 2 3 2 
Bovine 
Total >300 62 1 134 (24) 3 21 3 
Functional 215 (38) 52 1   79 (19) 3 16 3 
	 7	
1.2.4 Diversity of the αβTCR repertoire 
Theoretically, V(D)J recombination has the capacity to produce a potential repertoire of 
1×1015 αβ TCRs. However, this repertoire could not be fully expressed in any individual and 
the influence of negative and positive selection during thymic development has been shown 
to place severe constraints on the TCR repertoire (reducing the pre-selection repertoire by 
~100 fold) that can be expressed within any individual (Correia-Neves et al. 2001). Attempts 
to directly estimate TCR diversity have suggested the expressed repertoire in mice and 
humans are much lower – approximately 2Î106 and 2.5 Î107 unique TCRs respectively 
(Arstila et al. 1999; Casrouge et al. 2000). NGS sequencing has also been applied to measure 
TCR diversity (Warren et al. 2011). Although in this study a total of 1,061,522 sequences 
were recorded from an individual, repetitive sampling from that individual showed limited 
overlap indicating that despite this intensive analysis the full TCR repertoire had not be 
captured (Warren et al. 2011).  
 
The highly diverse TCR repertoire in conventional T-cells confers the ability to recognize a 
broad range of antigenic epitopes and so combat the wide range of pathogens to which 
individuals can be exposed. The highest TCR diversity is present in the naïve compartment; 
following antigen exposure TCR diversity is narrowed as antigen-driven selection leads to 
expansion of specific TCR clonotypes (Rudd et al. 2011). 
 
1.2.5 αβ TCR interaction with peptide-MHC complex 
The ligands for conventional CD8+ and CD4+ T-cells are peptide-MHC-I complexes 
(pMHC-I) peptide-MHCII complexes (pMHCII) respectively. Crystallographic studies have 
enabled the structure of the TCR/pMHC binding to be determined (Kass et al. 2014). In 
general, αβ TCRs bind to the pMHC in a conserved diagonal orientation (Figure 1.5), 
although there is considerable variation in the binding angle which can vary by up to +45o 
(Rudolph et al. 2006; Teng et al. 1998). As a consequence of the binding orientation the 
hypervariable CDR3s of the α and β chains have the most intimate association with antigen 
peptide component of the peptide-MHC (pMHC) complex while the CDR1 and CDR2 are 
predominantly involved in the interaction with the MHC helices (Figure 1.5). Thus, the most 
variable parts of the TCR dominate the binding of the most variable part of the pMHC ligand, 
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whilst the more conserved CDR1 and CDR2 dominate the binding to the more conserved 
MHC. 
 
Studies using alanine-screening mutagenesis show that different TCRs binding to the same 
pMHC ligand are reliant on different amino acid residues of the presenting peptide (Manning 
et al. 1998; Borg et al. 2005). This data demonstrates that the contribution of CDR loops to 













Figure 1.5 αβTCR interaction with pMHC ligands. (A) Lateral review of TCR/pMHC complex. αβ TCR on top 
(α chain in blue, β chain in brown), pMHC on bottom. Peptide in pink (Patel et al. 2013). (B) “Diagonal” 
docking mode of the CDR loops of a conventional TCR. CDR1α, CDR2α, and CDR3α -green, CDR1β, CDR2β, 










1.3 Non-conventional T cells  
Besides the majority conventional αβ T cells, there are many other αβ T cell subsets 
possessing distinct features, which include CD1-restricted T cells and MR1-restricted 
mucosal associated invariant T cells (MAIT cells). These cells are often termed ‘non-
conventional’ T cells and are characterised by recognizing non-polymorphic antigen-
presenting molecules rather than peptide-MHC complexes. The common feature of 
unconventional T cells is co-expression of a T cell receptor and natural killer (NK) cell 
receptors on the cell surface and possession of both innate and adaptive immune cell 
characteristics.  
 
1.3.1 CD1-restricted T cells 
CD1 (cluster of differentiation 1) is a family of non-polymorphic class I MHC related 
antigen-presenting molecules, which are expressed on various types of cells, including 
monocytes, macrophages and dendritic cells (DCs). In humans and other mammals, CD1 
molecules have been classified into four types and two groups: group 1 (CD1a, CD1b and 
CD1c) and group 2 (CD1d) (Calabi et al. 1989). Mice and rats have CD1d only. Evidence 
now strongly indicates that each CD1 type has a distinct function and specificity for 
particular lipid antigens (Kasmar et al. 2009; Van Rhijn et al. 2015). The group 1 CD1 
molecules have been characterized most extensively in humans and have been demonstrated 
to present microbial lipid antigens and certain self-lipids to a diverse group of T cells (Felio 
et al. 2009). The group 2 CD1 molecule-CD1d is able to activate natural killer T cells by 
presenting lipid antigens (Girardi and Zajonc 2012).  
 
1.3.1.1 Group 1 CD1-restricted T cells 
Different from MHC molecules, the group 1 CD1 molecules are highly expressed on the cell 
surface of CD4+ CD8+ cortical thymocytes and APCs (Brigl and Brenner 2004). CD1c is the 
most extensively expressed group 1 CD1 molecule, which can be found on B cells, 
monocyte-derived DCs, and Langerhans cells (Sugita et al. 2000). Meanwhile, CD1a and 
CD1b molecules are limited to expression on skin resident DCs and myeloid-derived 
dendritic cells, respectively (Wollenberg et al. 1996; Olivier et al. 2013). However, the 
expression of group 1 CD1 can also be regulated by various cytokines and different 
infections. For example, GM-CSF and IL-4 can increase the expression of group 1 CD1 by 
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promoting DCs differentiation, and infection with Mycobacterium leprae and Borrelia 
burgdorferi also can cause high levels of group 1 CD1 expression (Kasinrerk et al. 1993; 
Sieling et al. 1999; Yakimchuk et al. 2011) .  
 
The group 1 CD1-restricted T cells have been implicated to play crucial roles in a variety of 
autoimmune and infectious diseases by producing multiple cytokines such as IFN-α, IFN-γ, 
IL-17, and IL-22. CD1a molecules can bind to the mycobacterial lipopeptide 
didehydroxymycobactin (DDM) (Moody et al. 2004), and the DDM-specific CD1a-restricted 
T cells can produce different levels of IL-2 in response to different DDM antigens (Young et 
al. 2009). The CD1c molecule has a unique antigen-binding mode and like CD1a also 
presents lipopeptide antigens to T cells. Phoshomycokeide (PM) is the only know antigen 
presented by CD1c molecule and can active CD1c-restricted T cells (Moody et al. 2000). The 
CD1b molecule has the biggest antigen-binding groove of the group 1 CD1 members and 
binds the most diverse array of lipid species, including  glucose monomycolate (GMM), 
mycolic acid, phosphatidylinositol mannosides (PIMs), glycerol monomycolate, 
sulfoglycolipids and lipoarabinomannans (LAM) (Siddiqui et al. 2015).  
 
Group 1 CD1-restricted T cells are known to have diverse TCRs, but CD1b-restricted T cells 
were recently described to express highly conserved TCRs composed of a TRAV1-2V segment 
rearranged with TRAJ9, and with limited CDR3α diversity (Van Rhijn et al. 2013). 
 
1.3.1.2 CD1d-restricted natural killer T cell 
The ‘natural killer’ T cells (NKT cells) are regarded as a bridge between the innate and 
adaptive responses and combine features of T cells and NK cells. These cells were referred to 
as ‘natural killer’ T cells in early studies. However, after decades of research, it is clear that 
the function of these cells is not only based on NK receptor expression, but depends more on 
the specificity of these cells for lipid antigens presented by CD1d (Bendelac et al. 2007). 
Based on the utilization of TCR-α and β genes, the CD1d restricted NKT cells can be divided 
into two types: type I NKT cells and type II NKT cells. 
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1.3.1.2.1 Type I NKT cells  
Type I NKT cells are also known as invariant NKT (iNKT) cells and express a semi-invariant 
TCR α-chain (Vα14-Jα18 in mouse, Vα24-Jα18 in human) paired with a limited but not 
invariant TCR β-chain (Vβ7, Vβ8 and Vβ2 in mice, Vβ11 in human) (Godfrey et al. 2004; 
Rossjohn et al. 2012). In the mouse, the type I NKT cells represent up to 50% of T cells in 
liver and bone marrow and 0.5-1% of T cells in the thymus, blood and peripheral lymph 
nodes (Godfrey Poulton et al. 2001). In contrast, iNKT cells are less frequent in human 
(around 0.1% of T cells in peripheral blood) (Chan et al. 2013). In human and mice, the 
majority of type I NKT cells either express CD4 or are double negative (DN) for the CD4 and 
CD8 receptor (Bendelac et al. 2007). 
 
iNKT cells are activated by foreign lipids derived from microbes, tumours, and allergens, as 
well as self-lipids. In the mouse, the iNKT cells are known as an important component for 
responding to various bacteria, viruses and parasites, and abundant evidence indicates that 
iNKT cells also play the same role in pathogen infection in humans. The marina sponge-
derived glycolipid α-galactosylceramide (α-GalCer) is the earliest discovered CD1d 
presented lipid antigen (Kawano et al. 1997), and later many other α-linked bacterial sources 
of the glycolipid antigens have been reported, such as Sphingomonas species-derived α-
glycuronosylceramides, α-galactosyldiacylglycerol from Borrelia burgdorferi, α-
glucosyldiacylglycerol from Streptococcus pneumonia and phosphatidylinositol 
tetramannoside , and a weak iNKT-cell antigen originally extracted from Mycobacteria spp 
(Godfrey et al. 2015). In addition, two potent self-antigens of iNKT cells have been 
discovered:  isoglobotrihexosylceramide (iGb3) and α-glucosylceramide (α-GlcCer) (Zhou et 
al. 2004; Brennan et al. 2011). Upon TCR recognition of the CD1d glycolipid complex, 
iNKT cells are capable of a rapid response and release of various chemokines and cytokines 
to influence the Th1 and Th2 immune response (such as IFN-γ and IL-4) (Fujii et al. 2002). 
Type I NKT cells are also able to regulate the function of antigen-presenting cells, 
macrophages, and B cells.  
 
In a previous study, a conserved, tilted and parallel docking mode of iNKT TCR-CD1d 
glycolipid complex was determined from the crystal structures (Patel et al. 2011), which 
indicates the iNKT TCRs recognise the lipid CD1d in a homologous fashion, despite the 
various glycolipid antigens and diverse TCRβ chain. This crystal structure also demonstrated 
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that a single α-GalCer/CD1d complex interacts with different mouse iNKT TCRs sharing the 
same α chain and adopt a similar docking topology (Figure 1.6). Accordingly, the conserved 
manner of iNKT TCRs docking onto CD1d is mainly dependent on the invariant α-chain of 
iNKT cells. Thus, the iNKT TCRs contact CD1d predominantly with the α-chain and 
recognise lipid antigen only through the CDR3α loop, suggesting that the α chain is 














Figure 1.6 Structure of mouse NKT TCRs in complex with mouse CD1d-αGalCer (Patel et al. 2011). (A) 
Vα14Vβ2 NKT TCR-CD1d-α-GalCer. α-GalCer-Magenta; CD1d heterodimer-gray; Vα14-cyan; Vβ2-pink; 
CDR1α-purple; CDR3α-yellow; CDR1β-teal; CDR2β-ruby; CDR3β-orange. (B) Vα14Vβ8.2 NKT TCR-CD1d-
α-GalCer. Vβ8.2. α-GalCer-Green; CD1d, Vα14, and CDR loops color coding as in A. (C) Vα14Vβ7 NKT 
TCR-CD1d-α-GalCer. Vβ7; α-GalCer-Dark blue; CD1d, Vα14, and CDR loops color coding as in A. (E) 
Footprint of Vα14Vβ2 on the surface of CD1d-α-GalCer. α-GalCer is shown in spheres. (F) Footprint of 
Vα14Vβ8.2 on the surface of CD1d-α-GalCer. (G) Footprint of Vα14Vβ7 on the surface of CD1d-α-GalCer. E 






1.3.1.2.2 Type II NKT cells 
The type II NKT cells express a diverse TCR repertoire and so are also known as diverse 
NKT (dNKT) cells. Different from type I NKT cells, type II NKT cells recognise different 
CD1d-associated ligands and cannot respond to α-linked glycolipids, such as α-GalCer. A 
widely studied antigen of type II NKT cells is sulfatide (Jahng et al. 2004), a sulphated form 
of β-galactosylceramide (β –GalCer).  
 
In recent studies, some distinct functions of type II NKT cells have been demonstrated by 
comparing mice lacking type I NKT cells (Jα18-deficient mice) with  mice lacking type I and 
II NKT cells (CD1d-deficient mice) (Terabe et al. 2005; Ambrosino et al. 2007). Type II 
NKT cells play an important immune-regulatory role in infection, autoimmune disease and 
tumour immune surveillance -  producing both pro-inflammatory cytokines (such as IFN-γ, 
TNF-α and IL-17) and anti-inflammatory cytokines (such as IL-4 and IL-10) (Fuss et al. 
2014).  
 
The binding mode of type II NKT TCRs combines features of both MHC-restricted T cells 
and iNKT cells. Like MHC-TCR interactions, both α chain and β chain contact the CD1d 
molecule with a diagonal orientation. However, similar to iNKT cells which recognise the 
epitope solely with α chain, the type II NKT TCRs recognise antigen exclusively with one 
chain but in this case the β chain (Girardi et al. 2012). The crystal structure and docking 







Figure 1.7 Crystal structure and docking orientation of a type II NKT TCR on the CD1d-LSF complex (Girardi 
et al. 2012). (a) Crystal structure of the mouse CD1d–LSF–Hy19.3 TCR complex. CD1d in gray; β2-
microglobulin (β2m) in aqua; TCR α-chain in blue; TCR β-chain in dark red; LSF in yellow. (b) TCR footprint 
and binding orientation of the mouse CD1d–LSF–Hy19.3 TCR complex. TCR α-chain- cyan; TCR β-chain-red.  
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1.3.2 Mucosal associated invariant T cells (MAIT cells) 
Mucosal-associated invariant T (MAIT) cells are a highly conserved αβ T cell subset, found 
in most mammalian species. MAIT cells are characterised by two features 1) they process the 
evolutionarily conserved semi-invariant TCR α chain, which is composed of Vα7.2-Jα33 
(TRAV1-2—TRAJ33) in human and Vα19-Jα33 (TRAV1-TRAJ33) in mice, that is 
associated with Vβ6 (TRBV19) and Vβ8 (TRBV13) in mice, and Vβ 2 (TRBV20) and Vβ13 
(TRBV6) in humans (Ussher et al. 2014) and 2). These cells can be activated by ligands 
presented by the MHC related-1 molecule MR1 (Treiner et al. 2003). In humans, the MAIT 
cells express an effector memory phenotype, expressing the CD161 receptor (Dusseaux et al. 
2011), so it has been hypothesised that they may generate effector or memory cells. Upon 
activation, the MAIT cells are able to participate in antibacterial immune responses, against 
pathogens such as Mycobacterium tuberculosis, Salmonella typhimurium, and Escherichia 
coil, by expressing proinflammatory cytokines (such as IFN-γ, IFN-α and IL-17) and acting 
as cytolytic effector cells (Le Bourhis et al. 2010). 
 
In previous studies, a conserved docking mode was observed in MAIT TCRs binding the 
epitope-MR1 complex. Similar to conventional T cells which interact with pMHC, both α 
and β chains contact with MR1 molecule and CDR3s loops (CDR3α and CDR3 β) are 
responsible for recognizing their variable ligands. The studies also suggest that the docking 
footprint does not vary with MR1-presented ligands. The crystal structure and footprint of 






Figure 1.8 The crystal structure and footprint of MAIT cells interact with MR1 (Patel et al. 2013). (A) MAIT 
TCR in complex with MR1–RL-6-Me-7-OH. MAIT TCR α-chain—cyan; MAIT TCR β-chain—salmon; 
CDR1α—purple; CDR2α—pink; CDR3α—yellow; CDR1β—teal; CDR2β—red; CDR3β—orange; RL-6-Me-7-
OH—magenta; and MR1—grey. (B) MAIT TCR–MR1–RL-6-Me-7-OH complex, CDR loops color coding as 
in A.   
A	 B	
	 15	
1.4 Bovine NKp46+ CD3+ T-cells  
The NKp46 (NCR1. CD335) is an activating receptor belonging to the natural cytotoxicity 
receptors (NCRs) (Lanier et al. 2005) whose expression is generally considered to be 
restricted to natural killer (NK) cells (Sivori et al. 1997). Thus, the CD3-NKp46+ phenotype 
has been used to identify and characterise NK cells in various mammalian species (Walzer et 
al. 2007). Triggering the NKp46 receptor on NK cells leads to the induction of cytokines 
such as IFN-γ and to cytolytic activity (Sivori et al. 1997).  
 
In human and mouse, the expression of NKp46 has been identified only on aberrantly 
activated T cells (Meresse et al. 2006; Narni-mancinelli et al. 2011; Tomasello et al. 2012). 
However, in recent studies, the expression of NKp46 has been observed on a minor fraction 
of T cells in various species, and the NKp46+ CD3+ T-cells have been defined as a novel 
non-conventional T cell subset. 
 
In cattle, the expression of NKp46 has been found on both αβ and γδ T cells, and there is now 
evidence that NKp46+ CD3+ T cells may play a role in the responses against Theileria parva 
and Mycobacterium tuberculosis, and it has been hypothesised that they may form a niche 
bridging the innate and adaptive immune response (Connelley, Longhi, et al. 2014). Thus, 
NKp46+CD3+ cells may offer a novel population to target in vaccination strategies. Bovine 
NKp46+CD3+ cells have been shown to recognize and respond to autologous TpM and the 
NKp46+CD3+ cell lines can be generated and maintained in vitro by co-culture with 
autologous T. parva-infected cells (Connelley et al. 2014). Functional analysis has 
demonstrated that cross-linking of both the NKp46 receptor and the CD3 complexes (i.e. 
TCR) can lead to cell activation, however, the function of TCR in mediating recognition of 










1.5 Analysis of TCR repertoire 
Analysis of the TCR repertoire has been used to address a wide variety of biological 
questions, such as analysis of the diversity of antigen-specific responses, examining the 
clonality of T cell responses, and tracking clonally expanded T-cell populations (reviewd in 
Rufer, 2005).In previous studies, a number of molecular tools have been used to analysis 
TCRs. Due to the potentially huge diversity of TCR repertoire, the capacity of analysis 
technologies to provide sufficient resolution of the repertoire has been the major challenge. 
Due to the more stringent allelic exclusion of the TRB chain rearrangement analysis 
(resulting in T-cells generally expressing only a single functional TRB chain but more 
frequently expressing two TRA chains) and the more prominent role CDR3B has in 
interaction with the peptide epitopes of pMHC complexes, many techniques have focused on 
analysis of the TRB chain. Vβ subfamily-specific monoclonal antibodies (Cose et al. 1995; 
Trautmann et al. 2005) and semi-quantitative RT-PCR (Lehner et al. 1995) have been 
commonly used to identify preferential Vβ gene expression but they can not delineate the 
CDR3β sequence and clonality of T-cell responses. Another two widely used  methods are 
spectratyping (immunoscope) and heteroduplex analysis (Bousso et al. 1998; Bernardin et al. 
2004) which both can provide some information on the CDR3 length distribution in addition 
to TRBV subgroup usage but provide limited data of  the sequence of the TCRβ-chains. Sub-
cloning and Sanger sequencing of individual TRB provides more complete information on 
the expressed TRB chains but due to the high costs and laborious effort required has 
generally only been used on a limited number of clones and so provides low resolution data 
of complex repertoires.  
 
Recently, high throughput next generation sequencing (NGS) technologies have been applied 
to analyzing TCR repertoires. Compared with previous molecular tools, NGS offers 
opportunities to perform unbiased, quantitative, time-efficient and cost-effective analysis of 
diverse TCR repertoire (Bolotin et al. 2012). The NGS platforms used include Illumina 
sequencing, Roche 454 sequencing, Ion torrent and SOLiD sequencing, among these 
techniques the Illumia sequencing offers the highest number of sequencing reads per run. For 
preparing the library of NGS, the most common strategy is using the switching mechanism at 
the 5'-terminus of the RNA transcript (SMART) and 5’ rapid amplification of cDNA ends 
(RACE) technologies. SMART uses reverse transcriptases to switch templates in cDNA 
synthesis process to insert a primer annealing site at the 5’end of the TCR chain transcripts. 
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RACE using primers specific to the TRC genes (3’) and the inserted primer (5’) then permits 
unbiased PCR amplification of the TCR chains (Quigley et al. 2011). To analysis the NGS 
data, establish specialized bioinformatic pipelines are essential to compensate and correct for  
errors of sequencing/PCR, identify and quantify the expressed TCR chains. Currently, the 
pipelines are available for human and mouse TCR data (Bolotin et al. 2013), however recent 
work in the Morrison group at Roslin have adapted these pipelines to analysis of bovine TRB 



















1.6 Aims and objectives of the project 
Currently, the ability of bovine NKp46+ CD3+ T cells to respond to T. parva-infected cells 
(TpM) has been demonstrated. Furthermore, functional analysis also indicates cell activation 
can be initiated by either NKp46 or CD3 signaling pathways (i.e. TCR), but whether the 
TCRs actually are required for recognition of autologous TpM has yet to be determined.  The 
aim of this study is to examine the TCR repertoire of NKp46+ CD3+ T-cells responding to T. 
parva to better understand the clonality of this response and determine if there is evidence of 
conserved/semi-conserved TCR usage that could indicate TCR mediated selection and so 
suggest a role for TCR in NKp46+ CD3+ cells recognition of this pathogen.  
 
The aim of this study is to analyze the TCR repertoire of TpM-stimulated NKp46+CD3+ 
populations to look for evidence of TCR selection that would indicate a role for TCR in 
mediating recognition of TpM. To enable this to be done the aim is to use high resolution 
NGS TRB sequence analysis to compare the TCR repertoires observed in TpM-stimulated 
and non-specific stimulated NKp46+CD3+ populations derived from naïve and T. parva-
immune animals. So far, TpM specific-stimulated NKp46+CD3+ cell lines have been 
generated successfully from naive and T. parva immunized cattle and generation and 
maintenance of NKp46+CD3+ cell lines through use of non-specific stimulant hasn’t been 
demonstrated. Thus to achieve the aim of the study the objectives are: 
i) Optimize generation of TpM specific-stimulated cell lines from T. parva 
immunized cattle. 
ii) Attempt to generate non-specific antigen stimulated NKp46+ CD3+ cell lines in 
vitro. 
iii) Apply NGS technology to characterize the TCR β chain (TCRB) repertoire of 
NKp46+ CD3+ cells responding to non-specific stimulant and T. parva to identify 









Chapter 2. Isolation and expansion of bovine NKp46+ CD3+ T cell lines 
 
2.1 Introduction 
In a recent study, bovine NKp46+ CD3+ T cells were isolated from naïve cattle, and in vitro 
cell lines generated and maintained by repeated stimulation with irradiated autologous 
Theileria parva infected cells (TpM). Experiments as part of that study confirmed that the in 
vitro NKp46+ CD3+ cell lines originated from the in vivo NKp46+ CD3+ cell population 
(Connelley, Longhi, et al. 2014). Functional analysis indicated that the NKp46+ CD3+ T 
cells could recognize and respond to TpM (e.g. by cytotoxicity), and cross-linking of CD3 
(i.e. stimulation of the TCR signaling pathway) led to cell activation (Connelley, Longhi, et 
al. 2014). However, the function of the TCR in mediating NKp46+CD3+ T cells recognition 
of TpM has still not been determined.  
 
During antigen-specific T-cell responses clonotypes bearing TCR capable of binding the 
antigen undergo proliferation, leading to an over-representation of expression of those TCR 
in the responding populations. The objective of this chapter is to generate parallel in vitro 
NKp46+CD3+ cell lines from animals by i) co-culture with autologous TpM and ii) using 
non-specific stimulants, to provide material for subsequent TCR analysis. Comparison of the 
TCR repertoire of these lines in the subsequent chapter will then be used to determine if TpM 
co-culture (and therefore antigen-specific stimulation) generates cell lines with TCR 
repertoires with defined features that would suggest NKp46+CD3+ cells are using TCR to 
recognize autologous TpM.  
 
The population of NKp46+CD3+ cells in the PBMC is small (0.1-1.7%) but it has been noted 
that following immunisation against T. parva the population shows a small but consistent 
expansion in size (Connelley – personal communication), suggesting they may have the 
capacity to form a memory population. Therefore, in this chapter initial experiments started 
using PBMC from animals that had been previously immunised against T. parva.  
Although attempts to generate NKp46+CD3+ cell lines by co-culture with autologous TpM 
were successful for all animals, it was not possible to generate and maintain NKp46+CD3+ 
cell lines using non-specific stimulation. Notably, and against expectations, NKp46+CD3+ 
cell lines appeared to be easier to generate from naïve than from immune animals. 
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2.2 Material and methods 
2.2.1 Experimental animals 
A total of 6 Friesian-Holstein cattle (302977, 202990, 202997, 702988, 106180, and 106222) 
obtained from the University of Edinburgh Farm were used in this study. Four animals 
(302977, 202990, 202997, and 702988) had been immunized with the Muguga stock of T. 
parva by the infection and treatment as described previously (Radley et al. 1975). Two 
animals (106180 and 106222) hadn’t been immunized against T. parva and were regarded as 
naïve animals. The MHC phenotypes of these animals had been partially determined using a 
panel of class I MHC-specific monoclonal antibodies as part of other ongoing studies (Ellis et 
al. 1999); 302977, 202990, 202997 carried the A10 MHCI haplotype whilst 106180 and 
106222 carried the A14 MHCI haplotype.  
 
2.2.2 Cellular techniques 
2.2.2.1 Conditions for cell culture 
All the cells were cultivated in complete culture media: RPMI1640 (Gibco, Paisley, UK) 
supplemented with 10% heat-inactivated Fetal Calf Serum (FCS) (Gibco, Paisley, UK), 50 µM 
2-mercaptoethanol, penicillin, streptomycin and glutamine solution (100x solution -Gibco, 
Paisley, UK). Cells were incubated in humid atmosphere at 37°C and 5% CO2 in air.  
 
2.2.2.2 Isolation of peripheral blood mononuclear cells (PBMC) 
Blood was obtained by jugular venupuncture and collected into citrate-phosphate-dextrose 
(CPD) anticoagulant.  Peripheral blood mononuclear cells (PBMC) were isolated by density 
gradient centrifugation over Ficoll-Paque Plus solution (GE Healthcare Life Sciences). 
Aliquots of 30ml of blood was carefully overlaid onto 20ml of Ficoll-Paque Plus  in pre-
labelled 50ml Falco tube and centrifuged at 2500rpm for 30 minutes with no brakes at room 
temperature. The PBMC layer was harvested and washed 3 times in PBS containing 2mM 
EDTA and then counted (using trypan blue solution haemocytometer). If the PBMC pellet 
appeared to contain high numbers of red blood cells (RBCs) then RBC lysis was performed 
as an additional step (prior to the final wash in PBS/EDTA) by resuspending the pellet in 5ml 
RBC lysis buffer (50ml 0.175M TRIS, pH 7.4 added to 450ml 0.16M Ammonium Chloride) 
pre-heated to 37oC, and then incubating at 37oC for 1 minutes.  
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2.2.2.3 Isolation of NKp46+ cells using pan mouse IgG Dynabeads 
The PBMC pellets were re-suspended into PBS+2mM EDTA+0.5% BSA to give final 
concentration of 5 × 107 cells/ml and incubated with 3ug/ml anti-ovine NKp46 mAb EC1.1 
(Connelley et al. 2011) for 30 minutes at 4oC.  Ten microliters of the immunomagnetic anti-
mouse Ig beads (Dynabeads pan mouse IgG, Life Technologies, Paisley, U.K.) were prepared 
for every 1ml of cells (5 ×107) by washing and re-suspending in PBS+2mM EDTA+ 0.5% 
BSA (in brief beads were placed in the magnet for 2 minutes, the fluid removed, washed once 
with 1ml of  PBS+ 2mM EDTA+ 0.5% BSA) before being replaced in the magnet, 
supernatant removed and the re-suspended in PBS+ 2mM EDTA+ 0.5% BSA). PBMC were 
washed in 50ml PBS+2mM EDTA at 1300rpm for 10 minutes for two washes, then 
incubated with the prepared Dynabeads for 30 minutes at 4oC on a rotator. After this 
incubation the cells were placed in a magnet, washed three times, and positively selected 
cells were collected. Cells were plated at 5 × 105 cells/ml in complete tissue culture media 
with 100U/ml recombinant human (rh) IL-2 (Chiron, Emeryville, CA) added at 100u/ml, in a 
24 well plate overnight in 37oC incubator to allow the beads to dissociate from the cells. On 
the following day, cells were harvested placed in the magnet for 2 minutes and the NKp46+ 
cells collect and counted.  
 
2.2.2.4. Isolation of NKp46+ CD3+ cells using flow cytometry sorting 
NKp46+ CD3+ population were isolated from NKp46+ cells by flow cytometry sorting. The 
NKp46+ cells were stained with primary antibodies: AKS6 (murine IgG2b anti-bovine 
NKp46) and MM1A (murine IgG1 anti-bovine CD3) mAbs (each at 1ug/ml), then incubated 
at 4oC for 15-20 minutes. Cells were then washed 3 times in PBS + 0.5%BSA before being 
stained with Alexa Fluor 488-conjugated anti-murine IgG2b and Alexa Fluor 647-conjugated 
anti-murine IgG1 Abs (Molecular Probes, Paisley, UK), both at 1ug/ml. Flow cytometry 
sorting was performed using a FACSAria III (BD Biosciences, Oxford, U.K.).  
 
2.2.2.5. Culture of Theileria parva infected cells (TpM) 
Infected Theileria parva cell lines for the six animals were previously established using well 
established techniques (Connelley—personal communication). TpM are maintained in culture 
(expanded into culture flasks and kept in a humidified atmosphere of 5% CO2 at 37oC) by 
replacing ½ or ¾ of the cell suspension with complete culture media every 2 days. Their 
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growth was frequently monitored by microscopic observation (clumps of cells and absence of 
dead cells).  
 
2.2.2.6 Generation of IL-2 non-specific NKp46+ CD3+ cell lines 
NKp46+ cells were plated at 2× 105 cells/ml and cultured with 100U/ml rhIL-2 in 96 round 
bottomed well plates (200ul/well). After 7 days of culture at 37°C in 5% CO2 in a humidified 
atmosphere, cells were counted and assessed for purity by flow cytometry, and 
NKp46+CD3+ cells purified by flow cytometric sorting. The purified NKp46+ CD3+ cells 
were re-stimulated with 100 U/ml of rhIL-2 and cultured under the conditions described 
above. The cell number and purity were counted and analyzed every 7 days before re-
stimulation with IL-2.  
 
2.2.2.7 Generation of Concavalin A (Con A) non-specific NKp46+CD3+ cell lines 
Following optimisation of generation of Con A non-specific stimulated NKp46+CD3+ cell 
lines, flow cytometry sorting of NKp46+ CD3+ cells was performed two days after 
Dynabead sorting (NKp46+ cells were plated at 2× 105 cells/ml and co-cultured with 100 
U/ml of rhIL-2 in 96-well round-bottom plates for 2 days). After flow cytometry sorting, 
purified NKp46+ CD3+ cells were stimulated with Con A (2.5ug/ml, Amersham biosciences, 
Uppsala, Sweden) and 100 U/ml of rhIL2 in 96-well round-bottom plates for 7 days under the 
same conditions. The cells were counted, re-stimulated and the purity were assessed every 7 
days.  
 
2.2.2.8 Generation of TpM-specific NKp46+ CD3+ cell lines 
Purified NKp46+ CD3+ cells were co-cultured with irradiated autologous TpM cells at 2× 
105 cells/ml (4:1 ratio) in 96-well round-bottom plates under the conditions described above, 
supplemented with 100 U/ml of rhIL2. Every 7 days the cell lines were assessed by flow 
cytometry, counted and re-stimulated cells with irradiated TpM. If required, cell lines were 
subjected to additional purification by flow cytometry.  
 
	 23	
2.2.2.9 Flow cytometry analysis 
Cells were re-suspended at <2x107cells/ml and 50µl aliquots were incubated for 30 min at 
4°C with 50µl of primary antibody: AKS6 (murine IgG2b anti-bovine NKp46) and MM1A 
(murine IgG1 anti-bovine CD3); both at a final concentration of 1ug/ml in PBS/0.5% 
BSA/0.2% sodium azide. Cells were washed 3 times in FACS buffer (PBS+0.5%BSA+Na 
azide) and then incubated for 30 min at 4°C with 50µl secondary antibody: Alexa Fluor 488-
conjugated anti-murine IgG2b and Alexa Fluor 647-conjugated anti-murine IgG1 Abs; both 
at 2ug/ml. Following another 3 washes in FACs buffer, analysis was completed on a 
FACSCalibur (BD Biosciences, Oxford, UK) flow cytometer. Cells were initially gated on 
FSC/SSC parameters to identify viable cells and 5x104 viable cell events were collected. 
















2.3.1 Optimisation of NKp46+ cell line generation 
Analysis of the frequency of NKp46+ CD3+ cells in PBMC using two-colour flow cytometry 
showed the percentage of the cells to be very low (varying from 0.14-0.26%) in both naïve 
and T. parva immunized animals (Table 2.1). Due to the low frequency of NKp46+ CD3+ 
cells and the absence of a single marker that could be used for cell sorting, it was decided to 
maintain the previous method of isolating the cells from ex vivo PBMC – i.e. sorting NKp46+ 
cells using Dynabeads (the frequency of NKp46+ cells in PBMC varied from 1.33-2.55%) 
followed by flow cytometric sorting of NKp46+ CD3+ cells after a short period of in vitro 
culture. Evaluation of NKp46+ isolation using the previously used parameters showed a 
recovery rate of 43-93% of the NKp46+ cells in the PBMC population with a purity of 
NKp46+ cells of 83-87%. An attempt to increase the recovery rate by doubling the Dynabead 
bead to cell ratio doubled the number of cells recovered (from 1.84×106 to 3.36×106) but the 
purity of NKp46+ cells dramatically reduced (from 83% to 52%), suggesting that the 
additional cells were largely NKp46- contaminants (data not shown).  
  T.parva immunized animals Naïve animals 
Animal 202997 202990 302977 702988 106222 106180 
PBMC 9×108 1.36×109 1×109 9×108 2×109 2×109 
NKp46+ CD3+ 
cells in total PBMC 0.18% 0.26% 0.16% 0.14% 0.22% 0.17% 
NKp46+ cells in 
total PBMC 2.55% 2.42% 1.40% 1.76% 1.87% 1.33% 
EXPECTED   
 NKp46+ cell 
number  





1.0×107         
57% cell lost 
2.8×107  





23% cell lost 
2.8×107  




Recovery rate of 
Dynabeads sorting 43% 85% 93% 77% 74% 53% 
Purification of 
NKp46+ cells 
NKp46+ cell: 83%-87%; NKp46+ CD3+ cells: 2%-4%;  
NKp46-CD3+ cells <3%; NKp46-CD3- cells: 6%-12% 
Table 1.1 Cell number of PBMC and the frequency of i) NKp46+ CD3+ cells and ii) NKp46+ cells of PBMC. 
Recovery rate of Dynabeads sorting; number and purification of NKp46+ cells. 
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During some attempts at NKp46+ isolation clumping of the cells was observed, leading to 
dramatically reduced numbers of cells recovered. This clumping appeared to occur after the 
washing to remove the NKp46+ antibody. To address this issue the effects of adding BSA or 
performing all stages of the cell isolation at 4oC was examined. The latter appeared to 
effectively avoid the cell clumping issue (data not shown). Consequently, it was decided to 
use the initial sorting protocol but perform all stages at 4oC.  
 
2.3.2 Generation of NKp46+ CD3+ cell-lines by non-specific stimulation 
2.3.2.1 Interleukin 2 (IL-2) stimulation for non-specific NKp46+ CD3+ cell line generation 
To address the study objective of comparing the TCR repertoire between non-specific 
stimulated and TpM specific-stimulated NKp46+ CD3+ cell lines, it was necessary to 
determine if NKp46+ CD3+ cells could be maintained in vitro using non-specific stimulants. 
Interleukin 2 (IL-2) is a potent T cell growth factor and has been shown to stimulate bovine 
NK cell proliferation in vitro (Liao et al. 2011). We hypothesised that IL-2 could be effective 
as a non-specific stimulant of NKp46+ CD3+ cells in vitro.  
 
To evaluate the effect of IL-2 alone as a stimulant of NKp46+ CD3+ cells, NKp46+ cells 
were isolated from 2 animals (702988 and 302977) and parallel cultures generated with ¼ of 
the NKp46+ cells cultured with autologous irradiated TpM and IL-2 (as described above) and 
¾ with IL-2 only. After 7 days in culture, a significant decline in total cell numbers was 
observed in all cultures, especially in non-specific stimulated cell lines (Table 2.2). Notably, 
the number of NKp46+ CD3+ cells in the non-specifically stimulated cultures also declined 
whereas in the TpM stimulated cultures there was an increase in NKp46+ CD3+ cell number 
(Table 2.2). After 7 days NKp46+ CD3+ cells were isolated from each culture by flow 
cytometry to a purity of >95% and re-stimulated using similar conditions. After a further 7 
days of culture the frequency to NKp46+ CD3+ cells in the culture from animal 702988 was 
91.3% (Figure 2.1) and the cell number had approximately doubled (Table 2.2), however the 
frequency of NKp46+ CD3+ cells in the culture from 302977 stimulated with TpM and IL-2 
was only 5.5% (probably due to contamination with highly proliferative T. parva-specific 
CD8+ T-cells – data not shown) despite an expansion following the second stimulation. In 
contrast, the cultures stimulated with IL-2 alone both continued to decline in number and the 
frequency of NKp46+CD3+ became negligible (0.32-0.38%), with NKp46-CD3+ T-cells 
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apparently the dominant population (Figure 2.1). Consequently, it was concluded that non-





TpM+ IL-2 Only with IL-2 TpM+ IL-2 Only with IL-2 
NKp46+ cells from 
Dynabeads sorting 3.0✕10
6 9.0✕106 3.25✕106 9.75✕106 











NKp46+CD3+ in NKp46+ 









NKp46+ CD3+ cells sorted 
by flow cytometry  3.56✕10
4 5.048✕103 3.64✕104 3.92✕103 
Total cell number after 7 









FACs analysis results Figure 2.1 
Table 2.2 Cell number results of animal 702988 and 302977 co-cultured with TpM+IL-2 and only with IL-2 











         













Figure 2.1. FACs analysis results of 7 days after flow cytometry sorting (7 days after second stimulation). The 








2.3.2.2. Concanavalin A (Con A) stimulated non-specific NKp46+ CD3+ cell line generation 
Concanavalin A (Con A) has the capacity to trigger T cell activation, proliferation, and 
differentiation. Con A was hypothesised as another potential non-specific stimulant of 
NKp46+ CD3+ cells and the ability to use this was therefore examined. 
 
Isolated NKp46+ cells were stimulated in vitro in parallel cultures with either i) IL-2, ii) IL-2 
+ TpM or iii) IL-2 + Con A to examine the effect of Con A as a non-specific stimulant for 
NKp46+ CD3+ cells. After 7 days in culture, the total cell number decreased by more than 2-
fold in both IL-2 and Con A+ IL-2 stimulated cell lines, but a dramatic increase (3-fold) was 
observed in the TpM stimulated cell line (Table 2.3). Flow cytometry analyses were 
performed after 7 days of cell culture to look at the phenotype of the cell lines. The results 
indicated that Con A promoted the proliferation of NKp46-CD3+ (i.e. T cell phenotype) cells 
(Figure 2.2), suggesting that NKp46-CD3+ cells need to be removed by flow cytometry 
sorting before addition of Con A. In the original protocol, cells were left for 7 days after 
Dynabead sorting to (i) ensure the removal of the Dynabeads from the cell surface and (ii) to 
allow recovery of NKp46 marker expression on the cell surface.  In order to determine if it 
was necessary to leave the cells 7 days for recovery, FACs analysis was performed 2 days 
after Dynabead sorting; cells were stained with i) secondary antibody only (to verify that the 
NKp46 monoclonal antibody used during the primary sort was no longer present) and ii) with 
sequential primary and secondary antibodies (to ensure that NKp46 was expressed at the cell 
surface at this time point). The results showed that the cells were not effectively stained with 
the secondary antibody (Figure 2.3) only but were effectively stained with primary/secondary 
antibody combination (Figure 2.3); this indicated that by 2 days post-Dynabead sorting the 
cells could be re-stained for a secondary flow cytometric sort to remove NKp46-CD3+ cells 
and this was adopted as the new protocol. 
 
Using this new protocol NKp46+CD3+ cells following the second, flow cytometric sort were 
equally divided into two aliquots and parallel cultures with either i) TpM+ IL-2 or ii) Con A+ 
IL-2 were established. FACs analysis performed after 7 further days of culture, indicated that 
the frequency of NKp46+ CD3+ cells in Con A stimulated cell line was only 0.37% and that 
the frequency of NKp46- CD3+ cells reached up to 96.7% (Figure 2.4). These results suggest 
that ConA was sufficiently biasing the proliferation of conventional T-cells over 
NKp46+CD3+ T-cells to not be useful as a non-specific stimulant in this project. For the 
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remainder of the study, cells were FACs sorted 2 days after Dynabeads stimulation as this 
gave a greater degree of purity.  
 
Animal 202997 With TpM + IL-2 Only with IL-2 With Con A+ IL-2 
Dynabeads sorting 
Total NKp46+ cells: 
1.0×107 
1/4 1/2 ¼ 
2.5×106 5×106 2.5×106 
Total cell number after 7 







Table 2.3 Cell number results of animal 202997 NKp46+ cell lines co-cultured with i) TpM+ IL-2, ii) only with 





















    
 
  
   
Figure 2.2. FACs analysis results of 7 days after Dynabeads sorting. The NKp46+ cell lines of animal 







202997 only with IL-2                               202997 with TpM+IL-2 
										202997	with	ConA+IL-2	
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Figure 2.3 FACs analysis results of NKp46+ cells after two days of Dynabeads sorting. The cells were stained 














 Figure 2.4. FACs analysis results of 7 days after flow cytometry sorting. The 302977 NKp46+ CD3+ cell lines 
were co-cultured either with TpM+ IL-2 or ConA+ IL-2.  
 











302977 with TpM+IL-2                                302977 with Con A+ IL-2 
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2.3.3 Generation of TpM-specific stimulation NKp46+ CD3+ cell lines from T. parva 
immunized animals 
Compared with the non-specific stimulated cell lines, in vitro generation of TpM-stimulated 
cell lines was much easier. In total, three TpM stimulated cell lines were generated from 
immunized animals (animal 302977, 202990 and 202997). The fold change in total cell 
number of the cultures (Figure 2.10, Table 2.4, Table 2.5, and Table 2.6) and the frequency of 
NKp46+ CD3+ cells (Figure 2.11) were determined 7 days after each stimulation with 
autologous TpM, and the corresponding fold-change in NKp46+CD3+ cell number was 
calculated (Figure 2.12). In all cell lines, the total cell number increased throughout the whole 
culture period (Figure 2.10), while the frequency of NKp46+ CD3+ cells decreased 
substantially after FACs sorting (first stimulation) but then steadily increased in the 
subsequent stimulations (Figure 2.11). For animal 302977 and 202990, a total of 1.6×106 and 
2.0×105 cells were collected in the final cell lines (after 5th and 3rd stimulation respectively) 
and the frequency of NKp46+ CD3+ cells was 96.7% and 90.8% respectively (Figure 2.5 and 
Figure 2.6). For animal 202997, 3.0×105 cells were harvested for TCR analysis following the 
fourth TpM stimulation; at this point the frequency of NKp46+ CD3+ cells was relatively 
low (66.0%) with the predominant contaminating population being NKp46+ CD3- cells 
(33.6% - Figure 2.7). However, as NKp46+ CD3- cells do not express rearranged TCR chains 
segments this contamination was considered acceptable as it should not interfere with the 

















FACs	sorting 7	days 14	days 21	days 28	days 35	days
Fold change and Accumulative of total cell number
106222 Fold change 106222 Fold change Accum
106180 Fold change 106180 Fold change Accum
202997 Fold change 202997 Fold change Accum
202990 Fold change 202990 Fold change Accum

















Figure 2.10 Fold change (compared to previous week) and Fold change accumulative (compared to number of 
cells at the beginning of the culture period) of total cell number for TpM specific-stimulated cell lines during 














FACs	sorting 7	days 14	days 21	days 28	days 32	days
Frequency of NKp46+ CD3+ cells









Figure 1.12. Fold change (compared to previous week) and Fold change accumulative of NKp46+ CD3+ cells 








of total cell 














1.3×104  95% 1.2✕104  




4.0×104    3.0-fold 
increase 
37.8% 1.5✕104 1.2-fold 
increase 




1.0×105    2.5-fold 
increase 
42.1% 4.2✕104 2.8-fold 
increase 




2.7×105    2.7-fold 
increase 
64.2% 1.7✕105 4.0-fold 
increase 




6.1×105    2.2-fold 
increase 
82.0% 5.0✕105 2.9-fold 
increase 
Final NKp46+ 





96.7% 1.5✕106 3.0-fold 
increase 
Table 2.4 The cell number of total cells and NKp46+ CD3+ cells and fold change of total cells and NKp46+ 





FACs	sorting 7	days 14	days 21	days 28	days 35	days
Fold change and Accumulative of NKp46+ CD3+ cells 
106222 Fold change 106222 Fold change Accum
106180 Fold change 106180 Fold change Accum
202990 Fold change 202990 Fold change Accum
202997 Fold change 202997 Fold change Accum









Procedure Cell Type 
Total Cells 
number 


















 95% 7.9✕104  
















 95% 2.5✕104  






















Table 2.5 The cell number of total cells and NKp46+ CD3+ cells and fold change of total cells and NKp46+ 





















































































Table 2.6 The cell number of total cells and NKp46+ CD3+ cells and fold change of total cells and NKp46+ 


































































Figure 2.5. FACs analysis result of the final cell 
line (7 days after 5th stimulation) for animal 
302977 
Figure 2.6. FACs analysis result of the final cell 
line (7 days after 3rd stimulation) for animal 
202990 
Figure 2.7. FACs analysis result of the final cell 
line (7 days after 4th stimulation) for animal 
202997 
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2.3.4 Generation of TpM-specific NKp46+ CD3+ cell lines from naive animals 
To allow a comparison of the TCR repertoires of TpM-stimulated NKp46+CD3+ populations 
from naïve and immunized animals, TpM-stimulated NKp46+ CD3+ cell lines were 
generated from naïve animals (animals 106180 and 106222). The total cell number and FACs 
analysis results for these two cell lines are shown in Table 2.7 and Table 2.8. For animal 
106180, the total cell number increased more than 30-fold after the first TpM stimulation and 
maintained a stable growth in the subsequent stimulations (Table 2.7). The cell line of animal 
106222 exhibited a similar growth trend, and after the first stimulation, the cell number 
increased more than 50-fold in 7 days (Table 2.8). Similar to the immunized animals, the 
frequency of NKp46+ CD3+ cells in both naïve cell lines decreased dramatically after the 
first stimulation and the slowly increased in the subsequent stimulations (Figure 2.11). A total 
of 1.0✕106	cells were collected for the 106180 cell line with NKp46+ CD3+ cells 
constituting >98% of the population (Table 2.7; Figure 2.8). To evaluate the evolution of the 
TCR repertoire following repeated TpM stimulations, 3 harvests of the cell line from animal 
106222 were collected – 7 days after the 2nd, 3rd and 5th stimulations. At each of these points 
the frequency of contaminating NKp46-CD3+ T-cells was < 2% (Table 2.8; Figure 2.9).  
 
In summary, a total of 7 TpM-stimulated NKp46+ CD3+ T cell lines were generated in this 
study, which included 3 cell lines from T. parva immunized animals (202990, 202997 and 
302977), one cell line from naïve animal 106180, and three cell lines from naïve animal 
106222 (collected after different numbers of in vitro stimulations). mRNA was prepared from 



























sorting  NKp46+ cells 4.0✕10
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Cell number 
after 2 days 
Dynabeads 
sorting 
NKp46+ cells 8.8✕105   
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2.1-fold 
increase 
79.1% NKp46+  
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Table 2.7 The cell number of total cells and NKp46+ CD3+ cells, and fold change of total cells and NKp46+ 









Procedure Cell Type Total cells number 
Fold change 













sorting  NKp46+cells 2.8✕10
7     
Cell number 
after 2 days 
Dynabeads 
sorting 
NKp46+cells 1.4✕107     







 95% NKp46+ 
CD3+ cells 
1.31✕105  
7 days after 
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 95% NKp46+ 
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2.2✕106  
7 days after 
FACs sorting  
(7 days after the 
Fifth TpM 











Table 2.8 The cell number of total cells and NKp46+ CD3+ cells and fold change of total cells and NKp46+ 





















































Figure 2.9. FACs analysis result of the final cell line (7 












Figure 2.8. FACs analysis result of the final cell 





The work in this chapter aimed to generate NKp46+ CD3+ cell lines by stimulation with 
either a specific stimulant (TpM) or a non-specific stimulant in order to allow subsequent 
investigation of the TCR repertoire of NKp46+ CD3+ cells. The results are based on in vitro 
studies and provide information on the total cell number and frequency of NKp46+ CD3+ 
cells after each stimulation in order to evaluate the proliferation of cell lines. TpM specific 
stimulated NKp46+ CD3+ cell lines were generated from both naïve and immune animals, 
but, despite several attempts, it was not possible to successfully generate non-specific 
stimulated NKp46+ CD3+ cell lines.  
	
The frequency of NKp46+ CD3+ cells in PBMC varies from 0.14-0.26% with no apparent 
difference between T. parva naïve and immune animals. Based on the cell isolation protocol 
from a previous study (Connelley, Longhi, et al. 2014), the Dynabeads sorting method was 
used to isolate the NKp46+ cells. This lead to NKp46+ cell recovery rates of 43-93% and 
purities of 83-87% The wide range of recovery rate may have been caused by i) loss during 
centrifugation, ii) miscalculation, and iii) clumping and consequent loss of cells when 
isolations were not carried out at low temperatures (on ice). An attempt was made to increase 
the recovery rate by doubling of the numbers of magnetic beads, but this was not successful.  
In future studies it may be worth investigating increasing the antibody concentration and the 
incubation time. The NKp46+ CD3+ cells were subsequently isolated from the purified 
NKp46+ cells by FACs sorting which permits sorting based on multiple parameters. 
FACs sorting is characterised by the high purity of the sorted cells (>95%) but also relatively 
low yield. To increase the NKp46+ CD3+ cell yield, the MACs sorting isolation method was 
also examined in this study, but the results indicate that the purity of the isolated cell lines 
was relatively low (data not shown). Therefore, FACS sorting was chosen as the preferred 
method to obtain pure NKp46+ CD3+ cell lines.   
 
IL-2 and Con A were investigated as non-specific stimulants for NKp46+ CD3+ cells in this 
study, but non-specific stimulated cell lines were not generated successfully. The primary 
function attributed to IL-2 is the capacity of enhance in vitro T cell proliferation and 
differentiation.  Thus IL-2 is regarded as a general cell growth factor and was added to all 
TpM specific and non-specific stimulated cell lines. Meanwhile, it was also regarded as an 
autonomous non-specific stimulant. The results indicate that the NKp46+ CD3+ cells 
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stimulated only with IL-2 were dying off following cell culture and repeated IL-2 non-
specific stimulation (the total cell number and frequency of NKp46+ CD3+ cells showed 
consecutive drops). Thus IL-2 was not an effective non-specific stimulant. Due to its ability 
to trigger T cell activation by directly interacting with T cell receptor, Con A was also 
hypothesized as non-specific stimulant in this study. However, the results indicate that Con A 
stimulation was not sufficient to maintain the purified NKp46+ CD3+ cells in vitro. A 
previous study demonstrated that NKp46+ CD3+ cells can be activated by the CD3 signally 
pathway (Connelley, Longhi, et al. 2014), thus we hypothesis that the failure to maintain 
purified NKp46+ CD3+ lines may be due to overgrowth by conventional T-cells or some 
form of defective signalling between the TCR and CD3 molecules. In a recent study, Con A 
was also used in an attempt to trigger the proliferation of porcine CD3+ NKp46+ cells but, 
similar to our findings, proliferation was not detected (Mair et al. 2016).  In further studies, 
non-specific stimulation of NKp46+ CD3+ cell lines could be attempted by maintainance 
with NK cell growth factors, such as IL-12, IL-15, IL-18, and IL-21 or alternatively by cross-
linking of either NKp46 +/- CD3 through cross-linking via well-bound antibodies. 
 
Compared with the IL-2 non-specific stimulated cell lines, a good cell proliferation was 
observed in the parallel cultured TpM-stimulated cell lines (Table 2.2; Figure 2.1).  The 
frequency of NKp46+ CD3+ cells was analysed 7 days after the second TpM stimulation in 
animal 702988 and was found to be 91.3% (Figure 2.1). In contrast, frequencies of 5.53% 
NKp46+ CD3+ cells and 92.1% NKp46- CD3+ cells were found in animal 302977 (Figure 
2.1). The marked proliferation of NKp46- CD3+ cells may have been caused by recall of 
contaminating conventional CD8+ T. parva specific memory T-cells in this immunized 
animal.  
 
TpM specific stimulated cell lines were generated successfully from both naïve and immune 
animals. However, compared with the immune cattle, the cell lines were much easier to 
generate from naïve cattle. The fold changes of total cell number are show in Figure 2.10, 
which indicates that after the first stimulation, 30.8 and 50.7-fold increases were observed in 
naïve animals 106180 and 106222 respectively, but only 2.3- 3-fold increases occurred in the 
three immune animals. After FACs sorting, the purity of NKp46+ CD3+ cell lines can reach 
more than 95%, however, it decreased dramatically (from more than 95% to 35-42%) after 
the first TpM stimulation in both naïve and immunized cell lines (Figure 2.12).  This is 
mainly caused by early proliferation of NKp46+ CD3- cell contaminants. In order to present 
	 41	
the proliferation of NKp46+ CD3+ cells in a visible way, the number of NKp46+ CD3+ cells 
was calculated based on the total cell number and the frequency of NKp46+ CD3+ cells, and 
the fold changes of the number of NKp46+ CD3+ cells is shown in Figure 2.12. The results 
demonstrated that after the first stimulation, the NKp46+ CD3+ cells increased more than 11-
fold in naïve animals but only around 1-fold increase in immune animals. Following 
subsequent stimulations, the results indicate that the number and frequency of NKp46+ 
CD3+ cells were growing steadily in both naïve and immune animals (Figure 2.11, Figure 
2.12).  
 
Consequently, after the first TpM stimulation, the substantial proliferation of the naïve 
NKp46+ CD3+ cells suggests that NKp46+ CD3+ cells may not form a long-term maintained 
memory population that enables a stronger recall in vitro. Further studies that track NKp46+ 
CD3+ cell responses from the same individual when naïve and then immune would be of 


























In a previous study panels of Vα and Vβ subgroup-specific primers were used to analyse the 
TCR repertoire of bovine NKp46+CD3+ cells (Connelley et al. 2008). The results from this 
study indicated the expression of a broad TCR repertoire, however such low resolution 
analysis of TCR repertoires cannot describe the clonality of the NKp46+CD3+ responding 
populations or identify if there are preferential usage of particular V-J combinations or 
selection for particular CDR3 lengths or motifs. Similar, in the absence of sequence data it is 
not possible to identify if there are ‘public’ TCRs that are characteristic for this population. 
To achieve a high resolution analysis of the TCR repertoire of NKp46+CD3+ populations it 
was decided to employ a NGS approach. 
In this chapter are presented results generated by NGS sequencing of the TRB chains of the 
TpM-stimulated NKp46+ CD3+ cell lines generated in the previous chapter. The objectives 
of this chapter are to use the high resolution TCR sequence data to examine; 1) the evolution 
of the clonality of NKp46+ CD3+ cells following repeated TpM stimulations, 2) the degree 
of clonality observed in the TpM-stimulated NKp46+CD3+ cell lines, 3) to examine if there 
is any evidence of conserved TRB chain sequences expressed by TpM-specific 
NKp46+CD3+ populations derived from different animals and 4) examine if there is any 
overlap between the TCR repertoires expressed by a TpM-stimulated NKp46+CD3+ 
population and a conventional TpM-specific CD8+ T-cell population derived from the same 
animal. Such analysis will help to define if there is evidence of TCR bias that would be 
consistent with a role for TCR in mediated NKp46+ CD3+ cell recognition of T. parva 









3.2 Material and methods  
3.2.1 Molecular techniques 
3.2.1.1 Isolation of mRNA  
Purification of mRNA was carried out using the Dynabeads® mRNA DIRECT™ 
Purification Kit (Life technologies—61011) according to the manufacturer’s instructions. 
300ul Lysis/Binding buffer was added per 1×106 cells and the DNA sheared by passing the 
lysate through a 21-gauge needle attached to a 2.5ml syringe. Lysed cells were then stored at 
-80°C until the rest of the mRNA isolation procedure was undertaken. For this 50ul aliquots 
of Dynabeads Oligo (dT)/1×106 cells were transferred to a RNAase-free 1.5ml micro-
centrifuge tube and placed in DynaMag2 1.5ml tube magnet holder (Life technologies 
12321D) for 30s and the cleared supernatant aspirated off. The tube was then removed from 
the magnet and 50ul of Lysis/Binding buffer added to the beads, and the wash repeated. The 
cell lysate was then added to the beads and mixed thoroughly by repeat pipetting to ensure 
complete re-suspension of beads in cell lysate. The bead/cell lysate mixture was then 
incubated with continuous rotation for 5 minutes at room temperature to allow hybridisation 
of the polyA of mRNA to the oligo (dT) on the beads. The mixture was then placed in the 
magnet for 2 minutes and the supernatant aspirated off. The beads were then washed twice 
with 600ul/×106 cells of Washing buffer A and followed by another two washes with 
Washing buffer B (300ul/×106 cells). Following these washed 5ul elution buffer/×106 cells 
was added to the beads and incubate at 65-80oC for 2 minutes; immediately following this the 
tube was placed in the magnet and the supernatant (containing mRNA) was transferred to a 
fresh microcentrifuge tube. The mRNA was then quantified by Nanodrop.  
 
3.2.1.2 Quality and conservation of mRNA 
The purity and concentration of mRNA were assessed by spectrophotometry (Nanodrop) with 
readings taken at 260 nm and 280 nm and the mRNA concentration calculated and the 260/280 





3.2.1.3 SMART-based TRB chain amplification  
This was performed as a 2-round PCR amplification. In the first round Phusion High-Fidelity 
PCR reactions with a final volume of 300µl were performed. These reactions were composed 
of: 60 µl Phusion HF Buffer (1x), 9µl DMSO (3%), 6 µl dNTP (200 µM), 15 µl Long UPM 
primer (0.5µM); CTA ATA CGA CTC ACT ATA GGG CAA GCA GTG GTA TCA ACG 
CAG AGT, and 15 µl TRBC II primer (0.5uM); GTCCGCGAGATCTCTGCTTC, cDNA 
12µl, molecular water 180µl and Phusion polymerase 3µl. The final reaction mixture was 
aliquoted into 6 tubes each with 50 µl. The optimized cycling conditions were: heated lid 
110°C, manual hot start at 98°C for 2 min, a first temperature step at 98°C for 30s, 20 cycles 
of (98°C for 10s, 65°C for 30s, 72°C for 60s) and a final extension period at 72°C for 10 min.  
	
After purification of the first round PCR product (see below), a second PCR reaction - using 
UPM.3 (0.5 µM) and TRBCivS (0.5 µM) primers (Table 3.1) with multiple sample identifier 
tags (allowing multiplexing of samples sent for sequencing) and the additional components 
required for direct sequencing of PCR products on the MiSeq Illumina platform. These 
reactions mixture are made in 600 µl final volume, with the Phusion High-Fidelity PCR Kit, 
containing: 120 µl Phusion Buffer (1x), 18 µl DMSO (3%), 12 µl dNTP (200 µM), 30 µl for 
each primer (Table 3.1), purified first round PCR products 60 µl, molecular water 360 µl and 
Phusion polymerase 6 µl. The final reaction mixture was distributed in PCR reaction tubes 
(50 µl/tube). The cycling conditions were: heated lid 110°C, manual hot start at 98°C for 2 
min, a first temperature step at 98°C for 30s, 10 cycles of (98°C for 10s, 65°C for 30s, 72°C 
for 60s) and a final extension period at 72°C for 10 min. Following this PCR, the products 
were purified, subjected to agarose gel electrophoresis, gel extracted to obtain the band of the 
anticipated size, and re-purified as described below.  
 
TRBCivs	reverse	Primers	
	 REV1-501	 REV2-502	 REV3-503	 REV4-504	 REV5-505	 REV6-506	
Illumine	adaptor	 AAT	GAT	ACG	GCG	ACC	ACC	GAG	ATC	TAC	AC	




	 FOR1-701	 FOR2-702	 FOR3-703	 FOR4-704	 FOR5-705	 FOR6-706	
Illumine	adaptor	 CAA GCA GAA GAC GGC ATA CGA GAT	
Multiple	tag	 AACTCTCG	 ACTATGTC	 AGTAGCGT	 CAGTGAGT	 CGTACTCA	 CTACGCAG	
Filler	 GTG ACT GGA GTT CAG ACG TGT GCT CTT CCG ATC T	
Gene-specific	 CTA ATA CGA CTC ACT ATA GGG CAA GCA G	
Table 2.1 illumina adaptor and Multiple sample tags present in the second round PCR primers 
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3.2.2 Agarose gel electrophoresis 
Agarose gel electrophoresis was conducted with 1.5% agarose/TAE gels (Bioline, London, 
UK). An intercalating agent of DNA (GelRed, Biotium, California, USA) was used to enable 
visualisation under UV light. Gels included a lane with a 1Kb Plus DNA Ladder 
(Thermofisher) to enable band size determination. Electrophoresis was conducted at 110 V 
for 50 min with TAE Buffer 1x as running buffer.  
 
3.2.3 Purification of PCR products 
The purification of PCR products after the first round and the second round PCR of NGS 
protocol were performed with QIAquick PCR Purification Kit (Qiagen, Manchester, UK) 
according to the manufacturer protocol except for the DNA elution step. The samples were 
eluted in water; 60 µl for the first round PCR and 100 µl for the second round PCR. The 
purification of the DNA fragments after excision from the electrophoresis gel were carried 
out with the QIAquick Gel Extraction Kit (Qiagen, Manchester, UK) following the 
manufacturer’s instructions. The final PCR product purification prior to NGS sequencing was 
conducted using AMPure XP Beads (Beckman Coulter, High Wycombe, UK) according to 
the manufacturer’s instructions.  In brief, an equal volume of beads and PCR products were 
thoroughly mixed and incubated for 15 min at room temperature. The samples were placed 
on a magnetic stand until the beads cleared from the supernatant. The supernatant was 
discarded and the beads washed twice with 200 µl of freshly prepared 75% ethanol. After the 
last wash, the samples were dried for 5 min at room temperature. The tubes were removed 
from the magnetic stand and the beads thoroughly re-suspended in 30 µl of molecular-grade, 
nuclease-free water. After 2 min incubation at room temperature, the tubes were placed on 
the magnetic stand, the water aspirated and transferred to a fresh tube.  
 
3.2.4. NGS, bioinformatics pipelines and VDJ analysis 
Samples for NGS analysis were submitted to Edinburgh Genomics for sequencing on an 
Illuminia Miseq platform. Samples were required to pass quality controls (Qubit DNA 
quantification, Agilent bioanalyzer for size determination) prior to sequencing. NGS sequence 
data was analyzed using the MiTCR bioinformatics pipeline which had been modified by Dr. 
Andy Law (Roslin Institute) to accept a bovine TRB database (constructed by Dr. Connelley, 
Roslin Institute). Non-functional TRB sequences were removed from the datasets prior to 
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subsequent analysis using algorithms that are part of the VDJ tools software package (done 
with the assistance of Deepali Vasoya - Roslin Institute).   
 
3.3 Results 
3.3.1 Preparation of PCR product for NGS  
From previous chapter, a total 7 NKp46+ CD3+ cell lines (302977, 202990, 202997, 106180, 
106222 2nd stimulation, 106222 3rd stimulation, and 106222 5th stimulation) were generated 
and prepared for PCR analysis. With the exception of the NKp46+ CD3+ cell line from 
animal 302977, all cell lines were successfully amplified by the SMART-based PCR. The 
forward and reverse primers used in the second round PCR for each cell line show in Table 
3.2. The final PCR products were purified by 1.5% TAE agarose gel and DNA bands of 
~700bp were extracted and purified, gel cutting results are shown in Figure 3.1.  
Animal  TRB Forwards primer sequencing TRBCivS primer sequencing 
106222 NKp46+ CD3+ cells 2nd  stimulation CGTACTCA ACTATCTG 
106222 NKp46+ CD3+ cells 3rd  stimulation AGTAGCGT TCATCGAG 
106222 NKp46+ CD3+ cells 5th  stimulation AACTCTCG TAGCGAGT 
106180 NKp46+ CD3+ cells ACTATGTC CGTGAGTG 
202997 NKp46+ CD3+ cells CTACGCAG CTGCGTGT 
202990 NKp46+ CD3+ cells AGTAGCGT ACTATCTG 
Table 3.2 Forward and reverse primers were used in the second round PCR of different NKp46+ CD3+ cell 
lines 
 















Ladder Ladder Ladder Ladder 
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The quality of the final purified PCR products were assessed by spectrophotometry 
(Nanodrop - Table 3.3), and the cDNA size were examined through running agarose gel 
electrophoresis with different volumes (10ul. 5ul, and 2.5ul) (Figure 3.2).  These purified 
PCR products passed the quality control (QC) with size of 660pb and ready for NGS. 
 
Table 3.3 Nanodrop results of the final PCR products 
	















Abs	 0.446	 0.463	 0.246	 0.6	 0.567	 0.319	
A260	10mm	
path	 0.896	 0.93	 0.485	 1.251	 1.234	 0.609	
A280	10mm	
path	 0.485	 0.529	 0.271	 0.678	 0.664	 0.33	
260/280	 1.85	 1.76	 1.79	 1.85	 1.86	 1.85	
260/230	 2.01	 2.01	 2.01	 2.09	 2.18	 1.91	
ng/ul	 44.8	 46.5	 24.3	 62.6	 61.7	 30.4	































3.3.2 NGS analysis of the expressed TRB repertoires 
The purified PCR products of the TpM specific stimulation NKp46+ CD3+ cell lines were 
sequenced in 2 separate MiSeq runs and the data analyzed using a modified MiTCR (Bolotin 
et al. 2013) bioinformatics pipeline.  
	
3.3.2.1 Evolution of the TRB repertoire during repeated TpM stimulations 
The TRB repertoires of NKp46+ CD3+ cell lines from animal 106222 following the 2nd, 3rd, 
and 5th stimulation with TpM in vitro were analysed to evaluate the evolution of the TRB 
repertoire during repeated TpM stimulations. The top 50 most frequent CDR3 sequences are 
shown in Table 3.4 (106222 2nd stimulation), Table 3.5 (106222 3rd stimulation), and Table 
3.6 (106222 5th stimulation). The evolution of TRB repertoire was assessed by i) changes of 
TRB diversity and ii) identification of dominant clonotype expansion. Rarefaction analysis 
(Figure 3.3) shows that the TRB diversity of the 2nd stimulation cell line is much higher than 
that observed in the 3rd stimulation, and the 5th stimulation is slightly lower than the 3rd 
stimulation, which indicates that the TRB repertoire narrowed following repeated TpM 
stimulation, with a substantial decline observed between the 2nd and 3rd stimulations.  
A ‘virtual spectratype’ analysis (Figure 3.4) shows that for the cell lines following the 2nd and 
3rd stimulation cell lines there is a ‘normal’ (Gaussian) distribution of the CDR3 length and 
generally few high frequency clonotypes. In contrast, in the 5th stimulation cell line there is a 
skewed distribution of CDR3 length, largely attributable to the expansion of the single 
dominant clonotype. Repertoire overlap analysis (Figure 3.5) of the clonotypes expressed in 
the different stimulated NKp46+ CD3+ cell lines shows a high levels of repertoire overlap 
between cell lines, with the frequency of most individual clonotypes changing slightly 
between the 2nd, 3rd and 5th stimulations but a substantial increase of a the clonotype 
TRBV28-1-CASSDPRTAGAVQLYF- TRBJ2-2 observed in the 5th stimulated cell lines 
(increase from 0.3% in 2nd stimulation and 0.5% in 3rd stimulation to 42.7% in 5th 
stimulation). This data indicates clonal selection and expansion in T. parva stimulated 
NKp46+ CD3+ cells.  
Representation of the frequency of TRBV and TRBJ gene usage are shown in Figure 3.6, it 
indicates that a broad selection of both TRBV and TRBJ genes are used in the NKp46+CD3+ 
cell lines. In the 2nd and 3rd stimulation cell lines there appears to be preferential usage of 
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TRBJ 3-2, 3-7, and 3-4, and TRBV 20-13, 9-9, and 7-1. As would be expected in the 5th 
stimulation the TRBJ2-2 and TRBV28-1 gene segments are dominant although the same 
gene segments preferentially using the in the 2nd and 3rd stimulation cell lines are also present 
at high frequency. 
Together this data shows that during repeated TpM stimulations in vitro the TRB repertoire 
narrowed in terms of clonotype diversity but maintained a broad usage of both TRBV and 
TRBJ genes and generally a range of CDR3 lengths. The expansion of a single dominant 
clonotype in the 5th stimulation skewed the spectratype and apparent TRBV and TRBJ usage. 
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106222 2nd stimulation 
#count freq cdr3aa v d j 
38732 7.46% CASSPLTSGGLNTQPLYF TRBV7-1 TRBD3 TRBJ3-2 
25334 4.88% CASSQDGQHRSYEQYF TRBV9-9 TRBD1 TRBJ3-7 
25200 4.86% CASSQADTLGTQYF TRBV9-9 TRBD1 TRBJ3-4 
23177 4.47% CGTLDWASTDTQYF TRBV20-03 TRBD2 TRBJ3-4 
22484 4.33% CGARPGGNAVQLYF TRBV20-10 TRBD3 TRBJ2-2 
16293 3.14% CSASCFGGGHEQYF TRBV20-13 TRBD3 TRBJ3-7 
15639 3.01% CSASGHLNTQPLYF TRBV20-13 TRBD2 TRBJ3-2 
13563 2.61% CSAAPGTQPLYF TRBV20-13 TRBD3 TRBJ3-2 
12975 2.50% CASSRTRAATDDYHF TRBV4-5 TRBD1 TRBJ1-2 
12354 2.38% CASSQEMRDPSYEQYF TRBV9-1 TRBD1 TRBJ3-7 
11549 2.23% CASVTSGQEIQYF TRBV28-1 TRBD3 TRBJ3-5 
10551 2.03% CATRGQGVYNNPLYF TRBV6-11 TRBD2 TRBJ3-3 
8796 1.70% CAGGQQLFAGAALTF TRBV27-1 TRBD1 TRBJ3-6 
6958 1.34% CASSRGMGEGSIDTQYF TRBV12-2 TRBD1 TRBJ3-4 
6729 1.30% CASSYYAAGYDYHF TRBV6-18 TRBD1 TRBJ1-2 
6641 1.28% CSAPDFGSGELHF TRBV20-13 TRBD3 TRBJ3-1 
6217 1.20% CASSQVERTYEQYF TRBV9-9 TRBD3 TRBJ3-7 
5726 1.10% CASSLAGHGELHF TRBV10-3 TRBD1 TRBJ3-1 
5542 1.07% CASSKDWGLGDYEQYF TRBV12-2 TRBD2 TRBJ3-7 
5067 0.98% CSAADFGGCTDTQYF TRBV20-08 TRBD3 TRBJ3-4 
4732 0.91% CSDWRGHTQYF TRBV20-13 TRBD2 TRBJ3-4 
4594 0.89% CGASTQESTQYF TRBV20-03 TRBD1 TRBJ2-3 
4553 0.88% CASSPRGADTQPLYF TRBV3-1 TRBD3 TRBJ3-2 
4488 0.86% CSARRWGGKTSNNPLYF TRBV20-08 TRBD3 TRBJ3-3 
4083 0.79% CSAISHNPLYF TRBV20-13 TRBD3 TRBJ3-3 
3793 0.73% CASSLRLRGTDTQYF TRBV10-3 TRBD3 TRBJ3-4 
3758 0.72% CASSRSGAYRNNPLYF TRBV4-3 TRBD3 TRBJ3-3 
3712 0.72% CASASQLGSLYF TRBV26-2 TRBD2 TRBJ3-3 
3524 0.68% CTCRLDSSYEQYF TRBVX-1 TRBD1 TRBJ3-7 
3071 0.59% CASSQVWVHTQPLYF TRBV9-25 TRBD2 TRBJ3-2 
2763 0.53% CASSYDRGISNNPLYF TRBV10-3 TRBD3 TRBJ3-3 
2583 0.50% CASTTGLKQLYF TRBV6-4 TRBD2 TRBJ2-2 
2566 0.49% CASSQEPTSNSYEQYF TRBV9-9 TRBD3 TRBJ3-7 
2428 0.47% CGASLGGGADTQYF TRBV20-02 TRBD3 TRBJ3-4 
2404 0.46% CASSRSRFGNDPLYF TRBV4-1 TRBD3 TRBJ3-3 
2372 0.46% CSGGDLSTDTQYF TRBV19-02 TRBD1 TRBJ3-4 
2201 0.42% CTSSPMNTQPLYF TRBV6-40 TRBD2 TRBJ3-2 
2160 0.42% CSARRKVPQPLYF TRBV20-13 TRBD1 TRBJ3-2 
2131 0.41% CASRPSYQMNAVQLYF TRBV21-8 TRBD1 TRBJ2-2 
2103 0.41% CGATGPRYTDTQYF TRBV20-02 TRBD1 TRBJ3-4 
2088 0.40% CTCSASGTALDEQYF TRBVX-1 TRBD1 TRBJ3-7 
1924 0.37% CSASGGVAQPLYF TRBV20-13 TRBD3 TRBJ3-2 
1908 0.37% CSAGATAAMDYHF TRBV29-1 TRBD1 TRBJ1-2 
1869 0.36% CASSDWGVLSWPLYF TRBV10-3 TRBD2 TRBJ3-3 
1726 0.33% CASSHPTFYDYHF TRBV21-9 TRBD2 TRBJ1-2 
1717 0.33% CAGRQTGTGSSKQYF TRBV9-30 TRBD2 TRBJ3-7 
1681 0.32% CASRRPRGEQYF TRBV10-3 TRBD3 TRBJ3-7 
1671 0.32% CASSDPRTAGAVQLYF TRBV28-1 TRBD1 TRBJ2-2 
1633 0.31% CSARGLGGFEQYF TRBV20-08 TRBD2 TRBJ3-7 
1566 0.30% CASSRDGGDYHF TRBV4-6 TRBD2 TRBJ1-2 
Table 3.4 Top 50 most frequent CDR3 sequencing of animal 106222 2nd stimulation NKp46+ CD3+ cell line 
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106222 3rd stimulation 
#count freq cdr3aa v d j 
28733 11.99% CASSPLTSGGLNTQPLYF TRBV7-1 TRBD3 TRBJ3-2 
12733 5.31% CGTLDWASTDTQYF TRBV20-03 TRBD2 TRBJ3-4 
12297 5.13% CASSIDFGEIYEQYF TRBV27-1 TRBD3 TRBJ3-7 
10716 4.47% CASVTSGQEIQYF TRBV28-1 TRBD3 TRBJ3-5 
10396 4.34% CASSQADTLGTQYF TRBV9-9 TRBD1 TRBJ3-4 
8446 3.52% CTCRLDSSYEQYF TRBVX-1 TRBD1 TRBJ3-7 
8022 3.35% CSAGRTSDLPLYF TRBV29-1 TRBD3 TRBJ3-3 
7178 2.99% CSASCFGGGHEQYF TRBV20-13 TRBD3 TRBJ3-7 
6408 2.67% CASSQEMRDPSYEQYF TRBV9-1 TRBD1 TRBJ3-7 
6231 2.60% CATRGQGVYNNPLYF TRBV6-11 TRBD2 TRBJ3-3 
6121 2.55% CASSYYAAGYDYHF TRBV6-18 TRBD1 TRBJ1-2 
4676 1.95% CASSRGMGEGSIDTQYF TRBV12-2 TRBD1 TRBJ3-4 
4181 1.74% CASSPTSDRNPLYF TRBV7-1 TRBD2 TRBJ3-3 
4118 1.72% CASSQDGQHRSYEQYF TRBV9-9 TRBD1 TRBJ3-7 
3985 1.66% CASSQVERTYEQYF TRBV9-9 TRBD3 TRBJ3-7 
3412 1.42% CASASNVGWVHEEQHF TRBV26-2 TRBD2 TRBJ2-1 
3236 1.35% CASASQLGSLYF TRBV26-2 TRBD2 TRBJ3-3 
3213 1.34% CASSYSTEREAVQLYF TRBV6-9 TRBD1 TRBJ2-2 
3073 1.28% CASRPSYQMNAVQLYF TRBV21-8 TRBD1 TRBJ2-2 
2656 1.11% CASSRDRRQSTQYF TRBV15-2 TRBD1 TRBJ2-3 
2607 1.09% CSASGHLNTQPLYF TRBV20-13 TRBD2 TRBJ3-2 
2576 1.07% CASSRTRAATDDYHF TRBV4-5 TRBD1 TRBJ1-2 
2463 1.03% CGARPGGNAVQLYF TRBV20-10 TRBD3 TRBJ2-2 
2021 0.84% CGASTQESTQYF TRBV20-03 TRBD1 TRBJ2-3 
1864 0.78% CSAGATAAMDYHF TRBV29-1 TRBD1 TRBJ1-2 
1768 0.74% CSGGSSLGTQYF TRBV19-02 TRBD1 TRBJ2-3 
1666 0.69% CASSYYSYEQYF TRBV6-18 TRBD2 TRBJ3-7 
1631 0.68% CASSWTIRPPSGKTYEQYF TRBV6-18 TRBD3 TRBJ3-7 
1475 0.62% CASSINPGGMILSDPLYF TRBV15-2 TRBD2 TRBJ3-3 
1412 0.59% CTSSPMNTQPLYF TRBV6-40 TRBD2 TRBJ3-2 
1405 0.59% CASSLAGHGELHF TRBV10-3 TRBD1 TRBJ3-1 
1233 0.51% CASSDPRTAGAVQLYF TRBV28-1 TRBD1 TRBJ2-2 
1224 0.51% CASSPTGGWETLYF TRBV21-8 TRBD2 TRBJ2-4 
1210 0.50% CSAAPGTQPLYF TRBV20-13 TRBD3 TRBJ3-2 
1134 0.47% CSARRWGGKTSNNPLYF TRBV20-08 TRBD3 TRBJ3-3 
1082 0.45% CASSQEPTSNSYEQYF TRBV9-9 TRBD3 TRBJ3-7 
1022 0.43% CASSLERIREEQHF TRBV6-9 TRBD3 TRBJ2-1 
1011 0.42% CASSSCWIGCTQYF TRBV14-1 TRBD1 TRBJ2-3 
989 0.41% CSAISHNPLYF TRBV20-13 TRBD3 TRBJ3-3 
987 0.41% CASSQVWVHTQPLYF TRBV9-25 TRBD2 TRBJ3-2 
981 0.41% CASSKDWGLGDYEQYF TRBV12-2 TRBD2 TRBJ3-7 
978 0.41% CASSHPTFYDYHF TRBV21-9 TRBD2 TRBJ1-2 
936 0.39% CASTTGLKQLYF TRBV6-4 TRBD2 TRBJ2-2 
921 0.38% CAGRQTGTGSSKQYF TRBV9-30 TRBD2 TRBJ3-7 
861 0.36% CAASRDPRVNTQPLYF TRBV19-04 TRBD1 TRBJ3-2 
816 0.34% CASSKVGTLISNDPLYF TRBV12-2 TRBD1 TRBJ3-3 
789 0.33% CASRQDWGVGGEEQHF TRBV6-18 TRBD2 TRBJ2-1 
751 0.31% SSPLTSGGLNTQPLYF TRBV6-19 TRBD3 TRBJ3-2 
739 0.31% CASSPRGADTQPLYF TRBV3-1 TRBD3 TRBJ3-2 
724 0.30% CASNVGGSNYDYHF TRBV9-33 TRBD1 TRBJ1-2 




106222 5th stimulation 
#count freq cdr3aa v d j 
83736 42.73% CASSDPRTAGAVQLYF TRBV28-1 TRBD1 TRBJ2-2 
9117 4.65% CASSPLTSGGLNTQPLYF TRBV7-1 TRBD3 TRBJ3-2 
5053 2.58% CASSQDGQHRSYEQYF TRBV9-9 TRBD1 TRBJ3-7 
4819 2.46% CASSQADTLGTQYF TRBV9-9 TRBD1 TRBJ3-4 
4786 2.44% CSGTTQPLYF TRBV20-13 TRBD1 TRBJ3-2 
3791 1.93% CGTLDWASTDTQYF TRBV20-03 TRBD2 TRBJ3-4 
3277 1.67% SSDPRTAGAVQLYF TRBV6-19 TRBD1 TRBJ2-2 
2838 1.45% CGARPGGNAVQLYF TRBV20-10 TRBD3 TRBJ2-2 
2824 1.44% CASSRGMGEGSIDTQYF TRBV12-2 TRBD1 TRBJ3-4 
2378 1.21% CASSQEMRDPSYEQYF TRBV9-1 TRBD1 TRBJ3-7 
2187 1.12% CSASCFGGGHEQYF TRBV20-13 TRBD3 TRBJ3-7 
2159 1.10% CASSRTRAATDDYHF TRBV4-5 TRBD1 TRBJ1-2 
1843 0.94% CASVTSGQEIQYF TRBV28-1 TRBD3 TRBJ3-5 
1764 0.90% CSASGHLNTQPLYF TRBV20-13 TRBD2 TRBJ3-2 
1452 0.74% CASSQVERTYEQYF TRBV9-9 TRBD3 TRBJ3-7 
1446 0.74% CASSIDFGEIYEQYF TRBV27-1 TRBD3 TRBJ3-7 
1433 0.73% CASRRDTQPLYF TRBV6-13 TRBD3 TRBJ3-2 
1348 0.69% CASSLGIQGAQDTQYF TRBV9-6 TRBD3 TRBJ3-4 
1338 0.68% CAGGQQLFAGAALTF TRBV27-1 TRBD1 TRBJ3-6 
1220 0.62% CSAAPGTQPLYF TRBV20-13 TRBD3 TRBJ3-2 
963 0.49% CASASQLGSLYF TRBV26-2 TRBD2 TRBJ3-3 
938 0.48% CATRGQGVYNNPLYF TRBV6-11 TRBD2 TRBJ3-3 
910 0.46% CASRPSYQMNAVQLYF TRBV21-8 TRBD1 TRBJ2-2 
908 0.46% CASSKDWGLGDYEQYF TRBV12-2 TRBD2 TRBJ3-7 
883 0.45% CASSQVWVHTQPLYF TRBV9-25 TRBD2 TRBJ3-2 
861 0.44% CSDWRGHTQYF TRBV20-13 TRBD2 TRBJ3-4 
841 0.43% CASSYYAAGYDYHF TRBV6-18 TRBD1 TRBJ1-2 
812 0.41% CASSRSGAYRNNPLYF TRBV4-3 TRBD3 TRBJ3-3 
810 0.41% CASSPRGADTQPLYF TRBV3-1 TRBD3 TRBJ3-2 
773 0.39% CASSRSRFGNDPLYF TRBV4-1 TRBD3 TRBJ3-3 
719 0.37% CTCRLDSSYEQYF TRBVX-1 TRBD1 TRBJ3-7 
715 0.36% CSARRWGGKTSNNPLYF TRBV20-08 TRBD3 TRBJ3-3 
707 0.36% CSGGLGIEQYF TRBV20-08 TRBD2 TRBJ3-7 
663 0.34% CASSHPTFYDYHF TRBV21-9 TRBD2 TRBJ1-2 
625 0.32% CSAPDFGSGELHF TRBV20-13 TRBD3 TRBJ3-1 
596 0.30% CASSLAGHGELHF TRBV10-3 TRBD1 TRBJ3-1 
584 0.30% CASASNVGWVHEEQHF TRBV26-2 TRBD2 TRBJ2-1 
534 0.27% CASSQEPTSNSYEQYF TRBV9-9 TRBD3 TRBJ3-7 
534 0.27% CSAGRTSDLPLYF TRBV29-1 TRBD3 TRBJ3-3 
527 0.27% CGASTQESTQYF TRBV20-03 TRBD1 TRBJ2-3 
497 0.25% CSAISHNPLYF TRBV20-13 TRBD3 TRBJ3-3 
483 0.25% CASSRDGGDYHF TRBV4-6 TRBD2 TRBJ1-2 
474 0.24% CASSLGTASEQYF TRBV4-6 TRBD1 TRBJ3-7 
463 0.24% CASSLRLRGTDTQYF TRBV10-3 TRBD3 TRBJ3-4 
455 0.23% CSAADFGGCTDTQYF TRBV20-08 TRBD3 TRBJ3-4 
451 0.23% CASSRDRRQSTQYF TRBV15-2 TRBD1 TRBJ2-3 
402 0.21% CASTTGLKQLYF TRBV6-4 TRBD2 TRBJ2-2 
384 0.20% CSASGGVAQPLYF TRBV20-13 TRBD3 TRBJ3-2 
382 0.19% CASSQGSGGAYEQYF TRBV9-26 TRBD3 TRBJ3-7 
377 0.19% CASRLRGNDPLYF TRBV6-7 TRBD3 TRBJ3-3 















Figure 3.3. Rarefaction analysis of TRB repertoire from the animal 106222 2nd, 3rd, and 5th stimulations. The 
number of unique clonotypes in a sub-sample (diversity) plotted against its size (Sample size). Solid and dashed 





























































Figure 3.4. ‘Virtual spectratype’ analysis of the NGS TRB sequence data. The length of the CDR3 sequence is 
plotted against the read frequency for each sample. The most frequent clones are shown as distinct coloured 










































Figure 3.5. Repertoire overlap analysis of the clonotypes present in NKp46+ CD3+ cell lines of animal 106222 




















































































Figure 3.6. Representation of the frequency of TRBV and TRBJ usage in the six samples analysed by NGS 
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3.3.2.2 Comparison of the TRB repertoire of NKp46+ CD3+ cell lines between different 
animals  
In this section, the TRB repertoires of NKp46+ CD3+ cell lines from animals 106180, 
106222 (5th stimulation), 202990 and 202997 were compared to address the study objective 
of determining the commonalties of TRB repertoire between different animals. The top 50 
most frequent CDR3 sequences of animal 106180, 202990 and 202997 are shown in Table 
3.7, Table 3.8 and Table 3.9 respectively.  
 
Rarefaction analysis (Figure 3.7) of NKp46+ CD3+ cell lines indicates that the animal 
106222 (5th stimulation – total of 1017 unique clonotypes identified) expressed the most 
diverse TRB repertoire, followed by animal 202990, 106180, and 202997 (total 1017, 509, 
229 and 223 unique clonotypes were identified respectively). Virtual spectratype analysis 
(Figure 3.4) shows a skewed distribution of CDR3 length and a single dominant clonotype 
expansion in all NKp46+ CD3+ cell lines.  
 
Comparison of the TRB repertoire overlap between the NKp46+CD3+ cell lines derived from 
the 2 naïve animals 106180 and 106222 (Figure 3.8) shows high levels of repertoire overlap 
(clonotypes accounting for 65% and 85% of reads in 106180 and 106222 respectively). Some 
of these clonotypes were expressed with high frequency in both naïve animals, such as 
CASSDPRTAGAVQLYF (42.7% in 106222 and 8.3% in 106180), 
CASSPLTSGGLNTQPLYF (4.6% in 106222 and 2.9% in 106180), 
CASSQDGQHRSYEQYF (2.5% in 106222 and 2.2% in 106180), CASSQADTLGTQYF 
(2.4% in 106222 and 2.3% in 106180), and CGTLDWASTDTQYF (1.9% in 106222 and 
3.5% in 106180). With regards to TRBV and TRBJ gene usage both cell lines exhibited a 
broad repertoire of usage, but notably for both TRBV and TRBJ the 4 most commonly used 
genes were the same, with the exception of the closely related TRBV7-1 in 106180 and 
TRBV7-2 in 106222 (Figure 3.6). Comparison of the spectratypes indicated that despite the 
similarity in the TRB clonotypes and gene usage between the cell lines the most dominant 
CDR3 lengths differed between the two lines.  
	
In contrast, there was no overlap of distinct characteristics of TRB chains (i.e. no TRBV and 
TRBJ gene segments or CDR3 size/motif) was observed either between two immunized 
animals (202990 and 202997) or between naïve and immunized animals (data not shown). 
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106180 NKp46+ CD3+ cell line 
#count freq cdr3aa v d j 
2562 25.07% CASSPLTARAVQLYF TRBV7-2 TRBD1 TRBJ2-2 
853 8.35% CASSDPRTAGAVQLYF TRBV28-1 TRBD1 TRBJ2-2 
357 3.49% CGTLDWASTDTQYF TRBV20-03 TRBD2 TRBJ3-4 
338 3.31% CASAPDFGTYEQYF TRBV26-2 TRBD3 TRBJ3-7 
305 2.98% CASSPLTSGGLNTQPLYF TRBV7-1 TRBD3 TRBJ3-2 
284 2.78% CASSQGSGGAYEQYF TRBV9-26 TRBD3 TRBJ3-7 
271 2.65% CASSLGTASEQYF TRBV4-6 TRBD1 TRBJ3-7 
235 2.30% CASSQADTLGTQYF TRBV9-9 TRBD1 TRBJ3-4 
233 2.28% CASSQDGQHRSYEQYF TRBV9-9 TRBD1 TRBJ3-7 
167 1.63% CASSSTPMNTQPLYF TRBV6-36 TRBD3 TRBJ3-2 
157 1.54% CASSRGMGEGSIDTQYF TRBV12-2 TRBD1 TRBJ3-4 
148 1.45% CGARPGGNAVQLYF TRBV20-10 TRBD3 TRBJ2-2 
113 1.11% CASSRTRAATDDYHF TRBV4-5 TRBD1 TRBJ1-2 
108 1.06% CASSQRTSGGHEQYF TRBV21-1 TRBD3 TRBJ3-7 
105 1.03% CSASCFGGGHEQYF TRBV20-13 TRBD3 TRBJ3-7 
96 0.94% CASSLGIQGAQDTQYF TRBV9-6 TRBD3 TRBJ3-4 
95 0.93% CASSMRASGGMGTQIQYF TRBV4-6 TRBD3 TRBJ3-5 
93 0.91% CASSQGTGYDYHF TRBV4-4 TRBD2 TRBJ1-2 
93 0.91% CSAPDFGSGELHF TRBV20-13 TRBD3 TRBJ3-1 
83 0.81% CSASLGLNYEQYF TRBV20-13 TRBD2 TRBJ3-7 
83 0.81% CSAISHNPLYF TRBV20-13 TRBD3 TRBJ3-3 
79 0.77% CSAQHGGSYEEQHF TRBV20-04 TRBD2 TRBJ2-1 
76 0.74% CASSLAGHGELHF TRBV10-3 TRBD1 TRBJ3-1 
75 0.73% CASSQEMRDPSYEQYF TRBV9-1 TRBD1 TRBJ3-7 
73 0.71% CASVTSGQEIQYF TRBV28-1 TRBD3 TRBJ3-5 
72 0.71% CSASGHLNTQPLYF TRBV20-13 TRBD2 TRBJ3-2 
67 0.66% CSAGFSGTDTQYF TRBV29-9 TRBD1 TRBJ3-4 
63 0.62% CASSSIRGVAGAALTF TRBV9-26 TRBD3 TRBJ3-6 
63 0.62% CASSIDFGEIYEQYF TRBV27-1 TRBD3 TRBJ3-7 
63 0.62% CASSPRGADTQPLYF TRBV3-1 TRBD3 TRBJ3-2 
59 0.58% CASSRSGAYRNNPLYF TRBV4-3 TRBD3 TRBJ3-3 
54 0.53% CATRGQGVYNNPLYF TRBV6-11 TRBD2 TRBJ3-3 
53 0.52% CAGGQQLFAGAALTF TRBV27-1 TRBD1 TRBJ3-6 
53 0.52% CASSPAGGIYGELHF TRBV9-26 TRBD2 TRBJ3-1 
47 0.46% CASSYYAAGYDYHF TRBV6-18 TRBD1 TRBJ1-2 
44 0.43% CASSSRLRLADTQYF TRBV6-36 TRBD3 TRBJ3-4 
40 0.39% SSPLTARAVQLYF TRBV6-19 TRBD1 TRBJ2-2 
39 0.38% CASSYDRGISNNPLYF TRBV10-3 TRBD3 TRBJ3-3 
39 0.38% CASSSEWGGGINEQYF TRBV4-4 TRBD2 TRBJ3-7 
39 0.38% CASSRDGGDYHF TRBV4-6 TRBD2 TRBJ1-2 
37 0.36% CSARRWGGKTSNNPLYF TRBV20-08 TRBD3 TRBJ3-3 
37 0.36% CASRPSYQMNAVQLYF TRBV21-8 TRBD1 TRBJ2-2 
37 0.36% CSAVEQAGVSYEQYF TRBV20-08 TRBD1 TRBJ3-7 
37 0.36% CSGTTQPLYF TRBV20-13 TRBD1 TRBJ3-2 
36 0.35% CTCRLDSSYEQYF TRBVX-1 TRBD1 TRBJ3-7 
34 0.33% SSDPRTAGAVQLYF TRBV6-19 TRBD1 TRBJ2-2 
34 0.33% CSDWRGHTQYF TRBV20-13 TRBD2 TRBJ3-4 
33 0.32% CASSPRDTYEQYF TRBV9-26 TRBD1 TRBJ3-7 
33 0.32% CSAAPGTQPLYF TRBV20-13 TRBD3 TRBJ3-2 
33 0.32% CGAREWVGQYF TRBV20-07 TRBD2 TRBJ3-4 
Table 3.7 Top 50 most frequent CDR3 sequencing of animal 106180 NKp46+ CD3+ cell line 
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202990 NKp46+ CD3+ cell line 
#count freq cdr3aa v d j 
593891 57.37% CASAALLAGAALTF TRBV26-2 TRBD1 TRBJ3-6 
266184 25.71% CASSQEGLSDERTEVFF TRBV9-25 TRBD2 TRBJ1-1 
78448 7.58% CAASSPPEQGSQIQYF TRBV19-01 TRBD2 TRBJ3-5 
13258 1.28% CASSLKVPYGELHF TRBV21-9 TRBD3 TRBJ3-1 
11823 1.14% SSQEGLSDERTEVFF TRBV6-19 TRBD2 TRBJ1-1 
7440 0.72% CASSSSTSGGALDGELHF TRBV3-1 TRBD3 TRBJ3-1 
4307 0.42% CASSQAHSRIDRLYF TRBV21-8 TRBD1 TRBJ1-4 
3800 0.37% CASSEDLGLRGQIQYF TRBV9-10 TRBD3 TRBJ3-5 
3351 0.32% CASSPGHLDQPLYF TRBV9-2 TRBD1 TRBJ3-2 
2904 0.28% CASSDPSGGVISNNPLYF TRBV4-1 TRBD3 TRBJ3-3 
2825 0.27% CASSQDRQASIYEQYF TRBV9-21 TRBD1 TRBJ3-7 
2296 0.22% CASNSGANNPLYF TRBV6-14 TRBD3 TRBJ3-3 
2060 0.20% CASAGPPNDYHF TRBV26-2 TRBD2 TRBJ1-2 
1874 0.18% CASSPMGGEQYF TRBV7-1 TRBD2 TRBJ3-7 
1655 0.16% CASRGPPDSYEQYF TRBV15-1 TRBD1 TRBJ3-7 
1469 0.14% CASSPPDLYDYHF TRBV21-11 TRBD3 TRBJ1-2 
1387 0.13% CSAGPGDNPLYF TRBV20-13 TRBD3 TRBJ3-3 
1331 0.13% CASSPGLRGNTQPLYF TRBV4-1 TRBD3 TRBJ3-2 
1231 0.12% CSARCSGGDWPLYF TRBV20-13 TRBD3 TRBJ3-3 
1107 0.11% CASSQDLLDFGAGAALTF TRBV9-25 TRBD3 TRBJ3-6 
1028 0.10% CSAAGDYDYHF TRBV20-05 TRBD3 TRBJ1-2 
859 0.08% CSARIRTAQRWPSYEQYF TRBV20-08 TRBD1 TRBJ3-7 
836 0.08% CSAVRGGRHNPLYF TRBV20-08 TRBD3 TRBJ3-3 
795 0.08% CASSDPRTAGAVQLYF TRBV28-1 TRBD1 TRBJ2-2 
785 0.08% CASSEDPWALFAGAALTF TRBV9-10 TRBD1 TRBJ3-6 
736 0.07% SSSSTSGGALDGELHF TRBV6-19 TRBD3 TRBJ3-1 
711 0.07% CASSSWRDTQPLYF TRBV9-10 TRBD3 TRBJ3-2 
698 0.07% CASSLGGRESTQYF TRBV9-25 TRBD2 TRBJ2-3 
636 0.06% CASSYSEPEECDYHF TRBV6-20 TRBD2 TRBJ1-2 
601 0.06% CAWSSHMPPGLGGDPLYF TRBV30-1 TRBD2 TRBJ3-3 
570 0.06% CASSSGTDYDYHF TRBV4-1 TRBD1 TRBJ1-2 
564 0.05% CSAREVRGEDGELHF TRBV20-08 TRBD3 TRBJ3-1 
516 0.05% CASSPPGHWGFAGAALTF TRBV7-2 TRBD2 TRBJ3-6 
447 0.04% CSAGEYTGTDTQYF TRBV29-1 TRBD1 TRBJ3-4 
425 0.04% CSAGGPIIGDYHF TRBV29-6 TRBD1 TRBJ1-2 
405 0.04% CASSQDFGESGSSTDTQYF TRBV9-1 TRBD3 TRBJ3-4 
397 0.04% CASSSTPMNTQPLYF TRBV6-36 TRBD3 TRBJ3-2 
396 0.04% CGASQPYHEQYF TRBV20-03 TRBD1 TRBJ3-7 
383 0.04% CGATDFGLSNNPLYF TRBV20-03 TRBD3 TRBJ3-3 
381 0.04% CASTGDFAGAALTF TRBV26-2 TRBD2 TRBJ3-6 
373 0.04% CASSVRTLTNDRLYF TRBV3-1 TRBD1 TRBJ1-4 
369 0.04% CAWSFRTTDEEQHF TRBV30-1 TRBD2 TRBJ2-1 
361 0.03% CSARKVAGSGVSVINNPLYF TRBV20-13 TRBD3 TRBJ3-3 
352 0.03% CASAPLRGDRPLYF TRBV26-2 TRBD3 TRBJ3-3 
344 0.03% CASSRYYSNSYEQYF TRBV15-1 TRBD3 TRBJ3-7 
323 0.03% CASSEPKGGLSTDTQYF TRBV28-1 TRBD3 TRBJ3-4 
312 0.03% SSLKVPYGELHF TRBV6-19 TRBD3 TRBJ3-1 
309 0.03% CASSQREIQYF TRBV9-26 TRBD1 TRBJ3-5 
301 0.03% CASSYNSRSYDYHF TRBV6-14 TRBD1 TRBJ1-2 
282 0.03% CASSQDRVGLYDYHF TRBV9-26 TRBD2 TRBJ1-2 
Table 3.8 Top 50 most frequent CDR3 sequencing of animal 202990 NKp46+ CD3+ cell line 
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202997 NKp46+ CD3+ cell line 
#count freq cdr3aa v d j 
434053 63.22% CASSHRQQLNNPLYF TRBV9-29 TRBD1 TRBJ3-3 
106831 15.56% CASSRGTDYDYHF TRBV12-1 TRBD2 TRBJ1-2 
71326 10.39% CASSQYLQEGDYHF TRBV9-26 TRBD1 TRBJ1-2 
24679 3.59% CASSHSGTDTQPLYF TRBV9-9 TRBD2 TRBJ3-2 
7034 1.02% SSHRQQLNNPLYF TRBV6-19 TRBD1 TRBJ3-3 
6702 0.98% CASCNSGGPTDTQYF TRBV6-14 TRBD3 TRBJ3-4 
5365 0.78% CASQVGRYSNNPLYF TRBV4-6 TRBD2 TRBJ3-3 
2547 0.37% CASSRGLDNPLYF TRBV9-11 TRBD3 TRBJ3-3 
2516 0.37% CASSQSGRGIGERYF TRBV21-9 TRBD2 TRBJ2-5 
2361 0.34% CGASYLGGGRTYEQYF TRBV20-07 TRBD2 TRBJ3-7 
2337 0.34% SSRGTDYDYHF TRBV6-19 TRBD2 TRBJ1-2 
2024 0.29% CASSPGQLHYHF TRBV21-11 TRBD1 TRBJ1-2 
1366 0.20% SSQYLQEGDYHF TRBV6-19 TRBD1 TRBJ1-2 
1229 0.18% CASSDPRTAGAVQLYF TRBV28-1 TRBD1 TRBJ2-2 
1072 0.16% CASSPRLRGGLPIELHF TRBV7-1 TRBD3 TRBJ3-1 
1050 0.15% CASSKLGRGPSDTQYF TRBV4-3 TRBD2 TRBJ3-4 
1007 0.15% CGAWEASYGELHF TRBV20-03 TRBD2 TRBJ3-1 
798 0.12% CASGNLRSTLNYDYHF TRBV9-16 TRBD1 TRBJ1-2 
721 0.11% CSAGLRGLYGELHF TRBV29-1 TRBD3 TRBJ3-1 
591 0.09% CSVAGQDYYGELHF TRBV29-1 TRBD1 TRBJ3-1 
512 0.07% CASSDAGRGHSYEQYF TRBV12-1 TRBD3 TRBJ3-7 
508 0.07% CASSNFGGALRTQPLYF TRBV6-18 TRBD3 TRBJ3-2 
455 0.07% CASSPLTARAVQLYF TRBV7-2 TRBD1 TRBJ2-2 
421 0.06% CASSLGIQGAQDTQYF TRBV9-6 TRBD3 TRBJ3-4 
374 0.05% CASSRRGRDTRTDTQYF TRBV6-14 TRBD1 TRBJ3-4 
315 0.05% SSHSGTDTQPLYF TRBV6-19 TRBD2 TRBJ3-2 
279 0.04% CAASISWGDLSETLYF TRBV19-09 TRBD2 TRBJ2-4 
259 0.04% CASSQGATTQPLYF TRBV21-1 TRBD1 TRBJ3-2 
259 0.04% CAGWTSSQIQYF TRBV24-2 TRBD1 TRBJ3-5 
252 0.04% CGARPGGNAVQLYF TRBV20-10 TRBD3 TRBJ2-2 
246 0.04% CASSLGTASEQYF TRBV4-6 TRBD1 TRBJ3-7 
217 0.03% CASASTGLLIDTQYF TRBV26-2 TRBD1 TRBJ2-3 
217 0.03% CASSYPDGNSYEQYF TRBV6-18 TRBD3 TRBJ3-7 
208 0.03% CASSPAGTARETLYF TRBV7-2 TRBD1 TRBJ2-4 
190 0.03% CASTSTQDYHF TRBV24-2 TRBD2 TRBJ1-2 
171 0.02% CASSSTPMNTQPLYF TRBV6-36 TRBD3 TRBJ3-2 
170 0.02% CASSPTVRVSGAALTF TRBV7-2 TRBD1 TRBJ3-6 
169 0.02% CSARGHSRASETLYF TRBV20-13 TRBD1 TRBJ2-4 
169 0.02% CASTLGANYDYHF TRBV9-26 TRBD3 TRBJ1-2 
129 0.02% CASSDWGVVVFAGAALTF TRBV28-1 TRBD2 TRBJ3-6 
112 0.02% CSGTTQPLYF TRBV20-13 TRBD1 TRBJ3-2 
111 0.02% CGLQEGNGELHF TRBV20-03 TRBD1 TRBJ3-1 
111 0.02% CSASVYEQYF TRBV20-04 TRBD1 TRBJ3-7 
106 0.02% CASSQGSGGAYEQYF TRBV9-26 TRBD3 TRBJ3-7 
105 0.02% CASSQVEGTYGELHF TRBV9-26 TRBD3 TRBJ3-1 
104 0.02% SSLGTAWGYHF TRBV6-19 TRBD1 TRBJ1-2 
102 0.01% CGASNGDSLLMNTEVFF TRBV20-02 TRBD1 TRBJ1-1 
102 0.01% CASSGTESNNPLYF TRBV6-39 TRBD1 TRBJ3-3 
100 0.01% CASSQRTSGAIRGELHF TRBV21-1 TRBD3 TRBJ3-1 
99 0.01% CASSRGMGEGSIDTQYF TRBV12-2 TRBD1 TRBJ3-4 





Figure 3.7 Rarefaction analysis of TRB repertoire from the animal 106222 (5th stimulations), 106180 NKp46+ 




















Figure 3.8. Repertoire overlap analysis of the clonotypes present in NKp46+ CD3+ cell lines of animal 106222 
































3.3.2.3. Comparison between TRB repertoires of autologous NKp46+ CD3+ T cells and 
CD8+ T cells  
Comparison of the TRB repertoires expressed by autologous TpM-specific NKp46+ CD3+ T 
cells and CD8+ T cells was performed to identify if NKp46+CD3+ T cells used any of the 
TRB used by conventional T cells, which could provide evidence of recognition of the same 
peptide-MHC ligands. The top 50 most frequent CDR3 sequences of 202990 and 202997 
conventional (NKp46-CD3+) CD8+ cell lines are shown in Table 3.10, and Table 3.11 (data 
from Dr. Timothy Connelley). Rarefaction analysis (Figure 3.7) indicates that the TRB 
diversity of the conventional CD8+ T cell lines was higher than that of the NKp46+ CD3+ 
cell lines, which may be in part a reflection of the smaller number of cells harvested for the 
NKp46+ CD3+ cell lines. Virtual spectratype analysis of the conventional CD8+ T cell lines 
(Figure 3.8) shows a skewed distribution of CDR3 length with expansion of a number of 
dominant clonotypes. There was evidence of preferential usage of particular TRBV and 
TRBJ genes (Figure 3.9) in both conventional CD8+ T-cell lines but these didn’t correspond 
to those observed in the matching NKp46+CD3+ cell lines. Repertoire overlap analysis 
showed no conserved TRB sequences indicating that NKp46+CD3+ and conventional 
NKp46-CD3+CD8+ T-cell lines are distinct and thus there is no evidence support recognition 
















202990 CD8+ T cell line 
#count freq cdr3aa v d j 
124745 25.87% CASSQSGAQGEEQHF TRBV9-2 TRBD1 TRBJ2-1 
77136 15.99% CASSYRDSHSQPLYF TRBV9-25 TRBD1 TRBJ3-2 
68793 14.26% CASSLGQPNDYHF TRBV6-4 TRBD1 TRBJ1-2 
35275 7.31% CASAESIVPNTQPLYF TRBV26-2 TRBD1 TRBJ3-2 
23038 4.78% CASSPTSDRSDTQYF TRBV3-1 TRBD3 TRBJ3-4 
20182 4.18% CSAGDRTSGASLYF TRBV29-6 TRBD3 TRBJ3-3 
16188 3.36% CASAESPGGGRAQIQYF TRBV26-1 TRBD2 TRBJ3-5 
9385 1.95% CASSDTAGQGELHF TRBV9-30 TRBD1 TRBJ3-1 
9363 1.94% CSARLGGGINNPLYF TRBV20-13 TRBD2 TRBJ3-3 
7241 1.50% CASSYQFGGAGEQYF TRBV9-30 TRBD3 TRBJ3-7 
6595 1.37% CASSVRTASYEQYF TRBV9-30 TRBD1 TRBJ3-7 
5678 1.18% CASSARQQGYAVQLYF TRBV28-1 TRBD1 TRBJ2-2 
4126 0.86% CASLPYNPLYF TRBV4-1 TRBD3 TRBJ3-3 
3278 0.68% CASSEDSTQIQYF TRBV9-22 TRBD2 TRBJ3-5 
3033 0.63% CASSQ*RAYTQPLYF TRBV9-25 TRBD1 TRBJ3-2 
2972 0.62% CASSRSGTAEDDYHF TRBV9-2 TRBD1 TRBJ1-2 
2897 0.60% CASSQSQIQYF TRBV14-1 TRBD3 TRBJ3-5 
2780 0.58% CASSLNSDSYEQYF TRBV21-11 TRBD1 TRBJ3-7 
2354 0.49% CGALIRGGYEQYF TRBV20-02 TRBD3 TRBJ3-7 
2244 0.47% SSLGQPNDYHF TRBV6-19 TRBD1 TRBJ1-2 
1929 0.40% CASSRDQIAAYFAGAALTF TRBV4-1 TRBD1 TRBJ3-6 
1828 0.38% CASSQDSDQIQYF TRBV9-22 TRBD1 TRBJ3-5 
1759 0.36% CASSVDWGETLYF TRBV9-30 TRBD2 TRBJ2-4 
1594 0.33% CGALGRNSYEQYF TRBV20-07 TRBD3 TRBJ3-7 
1525 0.32% CSALPTAGYAIQYF TRBV29-1 TRBD1 TRBJ3-5 
1475 0.31% CASSQDVGGSLETLYF TRBV9-25 TRBD2 TRBJ2-4 
1473 0.31% CASSEGIAAETLYF TRBV9-10 TRBD1 TRBJ2-4 
1425 0.30% CASGSGSERYF TRBV25-1 TRBD2 TRBJ2-5 
1421 0.29% CSAKGGGGINNPLYF TRBV20-13 TRBD2 TRBJ3-3 
1399 0.29% CASSQFPGNYDYHF TRBV21-11 TRBD1 TRBJ1-2 
1399 0.29% CGALGRGGYEQYF TRBV20-02 TRBD3 TRBJ3-7 
1378 0.29% SSQSGAQGEEQHF TRBV6-19 TRBD1 TRBJ2-1 
1367 0.28% CASSSSQIQYF TRBV14-1 TRBD1 TRBJ3-5 
1170 0.24% CGARDTAMSDYHF TRBV20-02 TRBD1 TRBJ1-2 
1096 0.23% CASGDSTKQYF TRBV12-1 TRBD1 TRBJ3-7 
1040 0.22% CASELGGLSQSTQYF TRBV9-1 TRBD2 TRBJ2-3 
979 0.20% CGALLRGGYEQYF TRBV20-02 TRBD3 TRBJ3-7 
974 0.20% CAASTPGQTIQAQNF TRBV19-04 TRBD1 TRBJ1-5 
895 0.19% CAIRDSSYGELHF TRBV25-1 TRBD1 TRBJ3-1 
878 0.18% CASSLTSSGGAYDNPLYF TRBV9-1 TRBD3 TRBJ3-3 
861 0.18% CASSQGGGWAQPLYF TRBV9-1 TRBD2 TRBJ3-2 
844 0.18% CGALRGNDRLYF TRBV20-03 TRBD3 TRBJ1-4 
829 0.17% CASSSSISGDRLYF TRBV9-25 TRBD1 TRBJ1-4 
696 0.14% CASSDIRGERAGRKQEQYF TRBV9-30 TRBD3 TRBJ3-7 
693 0.14% CASSQEAGANPEVFF TRBV9-25 TRBD3 TRBJ1-1 
651 0.13% CASSRTENNPLYF TRBV21-1 TRBD1 TRBJ3-3 
589 0.12% CASTGTASYEQYF TRBV6-18 TRBD1 TRBJ3-7 
578 0.12% SSYRDSHSQPLYF TRBV6-19 TRBD1 TRBJ3-2 
556 0.12% CGLQEGNGELHF TRBV20-03 TRBD1 TRBJ3-1 
540 0.11% CASSEARTPINNPLYF TRBV9-30 TRBD2 TRBJ3-3 
Table 3.10 Top 50 most frequent CDR3 sequencing of animal 202990 CD8+ T cell line 
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202997 CD8+ T cell line 
#count freq cdr3aa v d j 
130959 23.25% CASSMRASGGMGTQIQYF TRBV4-6 TRBD3 TRBJ3-5 
51374 9.12% CASSQRTSGGHEQYF TRBV21-1 TRBD3 TRBJ3-7 
41308 7.33% CAWSLGLGAVQLYF TRBV30-1 TRBD2 TRBJ2-2 
37900 6.73% CASSQRTAGTGGYEQYF TRBV21-1 TRBD2 TRBJ3-7 
33176 5.89% CTSSYAPTAGNGDRLYF TRBV6-40 TRBD1 TRBJ1-4 
30902 5.49% CASTDLGRRGMDGELHF TRBV6-9 TRBD3 TRBJ3-1 
29919 5.31% CSAARRSGGSNNPLYF TRBV29-6 TRBD3 TRBJ3-3 
17554 3.12% CASSQRTSGAIRGELHF TRBV21-1 TRBD3 TRBJ3-1 
17366 3.08% CASSVQGSSRARLGNSPLHF TRBV9-10 TRBD1 TRBJ1-6 
15309 2.72% CASSQRGAKDTQYF TRBV21-1 TRBD3 TRBJ3-4 
9959 1.77% CASSPSYGAGEQYF TRBV3-1 TRBD3 TRBJ3-7 
9894 1.76% CASSLGIQGAQDTQYF TRBV9-6 TRBD3 TRBJ3-4 
7660 1.36% CASSREIDEQYF TRBV15-2 TRBD1 TRBJ3-7 
7336 1.30% CASSSGSRGNPLYF TRBV6-36 TRBD1 TRBJ3-3 
6804 1.21% CASSLGQRDYHF TRBV9-9 TRBD2 TRBJ1-2 
6771 1.20% CASSYGRLGVLMEEQHF TRBV10-3 TRBD2 TRBJ2-1 
6659 1.18% CASSSRGSHSQSTQYF TRBV21-1 TRBD3 TRBJ2-3 
6471 1.15% CASSRRDSGAYEQYF TRBV21-1 TRBD1 TRBJ3-7 
4942 0.88% CASSLSGGEDTQYF TRBV9-6 TRBD3 TRBJ3-4 
4596 0.82% CASSSNEGSYEQYF TRBV3-1 TRBD1 TRBJ3-7 
4245 0.75% CSGGTRDTNDRLYF TRBV19-02 TRBD1 TRBJ1-4 
3263 0.58% CASSHGLASETLYF TRBV9-11 TRBD2 TRBJ2-4 
2868 0.51% CASGGRSSYEEQHF TRBV24-2 TRBD1 TRBJ2-1 
2785 0.49% CSAGRGRNNPLYF TRBV29-3 TRBD2 TRBJ3-3 
2680 0.48% CASSQGIHPQTQPLYF TRBV9-6 TRBD1 TRBJ3-2 
2509 0.45% SSMRASGGMGTQIQYF TRBV6-19 TRBD3 TRBJ3-5 
2454 0.44% CTCSKDRGSQIQYF TRBVX-1 TRBD1 TRBJ3-5 
2387 0.42% CASSYSGQPGTEVFF TRBV6-9 TRBD1 TRBJ1-1 
2380 0.42% CASSQRTSGGGEQYF TRBV21-1 TRBD3 TRBJ3-7 
2187 0.39% CAWSLSRGDEQYF TRBV30-1 TRBD2 TRBJ3-7 
2175 0.39% CASNIGGAGEQYF TRBV24-2 TRBD1 TRBJ3-7 
2038 0.36% CASGRG*QAYHF TRBV9-11 TRBD1 TRBJ1-2 
1915 0.34% CASSVASNAVQLYF TRBV3-1 TRBD1 TRBJ2-2 
1879 0.33% CASSLNAVQLYF TRBV6-9 TRBD1 TRBJ2-2 
1832 0.33% CASSREDSSDDRLYF TRBV15-2 TRBD1 TRBJ1-4 
1644 0.29% CASSDGLATDNNPLYF TRBV9-29 TRBD1 TRBJ3-3 
1611 0.29% CASSWGVGQSTQYF TRBV9-25 TRBD2 TRBJ2-3 
1436 0.25% CASDWGGEQHF TRBV15-2 TRBD2 TRBJ2-1 
1408 0.25% CGAPDPKGVSYDYHF TRBV20-03 TRBD2 TRBJ1-2 
1304 0.23% CATGDSARTQPLYF TRBV10-3 TRBD1 TRBJ3-2 
1263 0.22% CASSDGLPGDYHF TRBV9-33 TRBD2 TRBJ1-2 
1112 0.20% CASSQDSGRNWGEGETLYF TRBV9-1 TRBD2 TRBJ2-4 
1086 0.19% CASSEMAAYYTQPLYF TRBV9-11 TRBD1 TRBJ3-2 
1056 0.19% CASSRAGRGDYHF TRBV15-2 TRBD3 TRBJ1-2 
1052 0.19% CASSREGRLGGDEETLYF TRBV15-2 TRBD2 TRBJ2-4 
1038 0.18% CASSLEAQDYHF TRBV6-4 TRBD1 TRBJ1-2 
1029 0.18% CASSPRGARDTQYF TRBV21-1 TRBD3 TRBJ3-4 
997 0.18% CASSQDMARNWDFGAGNNPLYF TRBV9-1 TRBD3 TRBJ3-3 
966 0.17% CASSQGGGGDGELHF TRBV9-6 TRBD2 TRBJ3-1 
939 0.17% CASSPLRGAGNNPLYF TRBV10-3 TRBD3 TRBJ3-3 




























Figure 3.9. ‘Virtual spectratype’ analysis of the NGS TRB sequence data of 202997 CD8+ T cells and 202990 
CD8+ T cells. The length of the CDR3 sequence is plotted against the read frequency for each sample. The most 
























Figure 3.10. Representation of the frequency of TRBV and TRBJ usage CD8+ T cell lines of animal 202997 




The work in this chapter describes the results from NGS analysis of TpM-specific stimulated 
NKp46+ CD3+ cell lines to provide higher resolution data on the expressed TRB repertoire.  
 
The rarefaction analysis data for the 106222 2nd, 3rd, and 5th stimulated cell lines from animal 
106222 demonstrated that the clonal diversity of T. parva-specific NKp46+ CD3+ cell lines 
narrowed during repeated TpM stimulations. As expected repertoire overlap analysis 
indicated that most of the clonotypes identified at the 3 time points were the same and that 
there was a progressive decrease in the number of reads coming from clonotypes not present 
at the other time points. A notable feature of these cell lines was the abrupt expansion of a 
single clonotype (TRBV28-1-CASSDPRTAGAVQLYF- TRBJ2-2) in the 5th stimulation  
that caused a dramatic skew in the virtual spectratype analysis and an apparent preference for 
that TRBV and TRBJ combination that was not present in the 2nd and 3rd stimulations. The 
reason for the remarkable expansion of this single clonotype is as yet unknown but may 
suggest a strong selection following sustained in vitro culture. Together the data is consistent 
with maintenance of a fairly stable but narrowing TRB repertoire in NKp46+CD3+ cells 
during multiple TpM-stimulations in vitro.  
 
In naïve animals 106180 and 106222, there was a significant overlap in the clonotypes 
(accounting for 65% and 85% of reads respectively), with many clonotypes expressed at high 
frequency in both animals. In contrast the TRB repertoires from the 2 T. parva-immunised 
animals were discrete with no clonotypic overlap with each other or the 2 naïve animals. 
Notably 106222 and 106180 were both BoLA-A14+ whereas 202997 and 202990 were not, 
however further data would be needed to verify if clonal selection was associated with 
MHCI-haplotype. Further data from more T. parva-naïve animals would also be required to 
evaluate in more detail if the degree of conservation of the TRB repertoire of NKp46+CD3+ 
cells was consistent. In all T. parva-specific NKp46+ CD3+ cell lines the most frequent TRB 
clonotypes accounted for 25-63% of total reads suggesting a clonal dominance and therefore 
selection. However, there was no clear pattern of consistent preference for TRBV, TRBJ or 
CDR3 sequence in the most dominant clonotypes making it difficult to make conclusions 
about preferred TRB sequences. 
 
Compare between the TCR repertoires of TpM specific NKp46+ CD3+ cells and CD8+ T 
cells from both 202997 and 202990 revealed no common TRB sequences. This is consistent 
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with the NKp46+CD3+ and conventional CD8+ T cell populations recognising distinct 
ligands. This suggests that the NKp46+CD3+ cells may, as expected not be specific to 































Chapter 4 Final conclusions 
 
During this study, the T. parva-specific stimulated NKp46+ CD3+ cells were maintained and 
generated in vitro from naïve and immunized cattle. In a previous study, the T. parva 
stimulated NKp46+ CD3+ cell lines were only generated from naïve animals (Connelley et 
al. 2014) and it had been hypothesised that NKp46+ CD3+ cells may have the capacity to 
form a memory population (Connelley – personal communication), and consequently that 
establishing T. parva-specific NKp46+CD3+ cell lines from immunised animals in vitro 
would be easier. However, in this study proliferation of T. parva-responsive NKp46+CD3+ 
cell lines was greater in naïve than in immunised animals, suggesting that if a memory 
population is formed the ability to recall it by in vitro stimulation is limited.  
 
The aim of this study was to analyze the TCR repertoire of TpM-stimulated NKp46+CD3+ 
populations to look for evidence of TCR selection that would indicate a role for TCR in 
mediating recognition of TpM. From a previous study (Connelley et al. 2014), panels of Vα 
and Vβ subgroup-specific primers suggested that NKp46+ CD3+ cells expressed a highly 
diverse TCR repertoire. To better determine this, a novel NGS high resolution approach for 
analysing bovine TRB repertoires has been applied to study T. parva-specific NKp46+CD3+ 
cell lines in this project. To identify the evolution of TCR repertoire following repeated T. 
parva stimulations, we analysed NKp46+ CD3+ cell lines from animal 106222 after the 2nd, 
3rd, and 5th stimulations, which provided evidence that following repeated T. parva 
stimulations the clonal diversity in the population was generally stable but did narrow. A 
remarkably high level of conservation between the TRB repertoires was observed between 
the 2 naïve animals in the study - 106180 and 10622 – but the repertoires of the 2 T. parva 
immunised animals were unique with no overlap with each other or the naïve animals. Whilst 
the high level of overlap between 106180 and 106222 provides evidence strongly suggestive 
of TRB involvement in the recognition of T. parva the lack of data of TRB repertoires in 
non-T. parva stimulated populations prevents firm conclusion being drawn. Unfortunately, 
the attempts to generate such lines in this study were unsuccessful and future work 
attempting other methods to generate non-specific lines (e.g. through cross-linking NKp46 or 
CD3 via well bound anti-NK46/CD3 antibodies) is warranted. Also necessary is the 
generation of data from further animals to verify the consistency of this TRB repertoire 
across animals of more diverse MHC haplotypes. 
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Of further interest is the fact that NKp46+CD3+ cell lines were more difficult to expand in 
vitro from immunised than naïve animals. This was contradictory to the starting expectation. 
When combined with the fact that the NKp46+CD3+ cell lines from the immunised animals 
were ‘private’ (i.e. unique to the individual animal) there is a possibility that in vivo exposure 
to the parasite is causing some substantial modification of the TRB repertoire of the 
NKp46+CD3+ - possibly suggestive of clonal deletion. Such an effect has obvious biological 
implications and needs further consideration – ideally experiments that track the 
NKp46+CD3+ responses longitudinally in individuals prior to and after an immunisation 
with T. parva. In any subsequent studies integration of analysis of the TRA chain repertoire 
would also be advantageous. 
 
In summary in this study a high resolution description of the TRB repertoire of bovine 
NKp46+CD3+ cell lines has been achieved. The data obtained suggests that in naïve animals 
there may be a highly conserved TRB repertoire used by T. parva-specific populations that is 
distinct from conventional CD8 T-cells. To fully appreciate the significance of the data 
further studies looking NKp46+CD3+ cell lines from more animals and selected under 
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